10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the quarterly period ended March 31, 2024 

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-15169

PERFICIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware		No.	74-2853258
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

555 Maryville University Drive

Suite 600

Saint Louis, Missouri 63141

(Address of principal executive offices)

(314) 529-3600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	PRFT	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days. þ Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). þ Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of April 25, 2024, there were 35,156,319 shares of Common Stock outstanding.

TABLE OF CONTENTS

 

Part I.	Financial Information	1
Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023	3
	Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023	4
	Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2024 and 2023	5
	Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2024 and 2023	6
	Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023	7
	Notes to Interim Unaudited Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	28
Item 4.	Controls and Procedures	29
Part II.	Other Information	29
Item 1A.	Risk Factors	29
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 5.	Other Information	30
Item 6.	Exhibits	31
	Signatures	32

PART I. FINANCIAL INFORMATION

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this Quarterly Report on this Form 10-Q (“Form 10-Q”) are not purely historical statements, discuss future expectations, contain projections of results of operations or financial condition, or state other forward-looking information. Those statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The “forward-looking” information is based on various factors and was derived using numerous assumptions. In some cases, you can identify these so-called forward-looking statements by words like “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. You should be aware that those statements only reflect our predictions and are subject to risks and uncertainties. Actual events or results may differ substantially. Important factors that could cause our actual results to be materially different from the forward-looking statements include (but are not limited to) the following:

(1)the impact of the general economy and economic and political uncertainty on our business;

(2)risks associated with potential changes to U.S. and foreign laws, regulations, and policies;

(3)risks associated with the operation of our business generally, including:

a. client demand for our services and solutions;

b. effectively competing in a highly competitive market;

c. risks from international operations including fluctuations in exchange rates;

d. adapting to changes in technologies and offerings;

e. the ongoing transition of our executive leadership team;

f. obtaining favorable pricing to reflect services provided;

g. risk of loss of one or more significant software vendors;

h. maintaining a balance of our supply of skills and resources with client demand;

i. changes to immigration policies;

j. protecting our clients’ and our data and information;

k. changes to tax levels, audits, investigations, tax laws or their interpretation;

l. making appropriate estimates and assumptions in connection with preparing our consolidated financial statements; and

m. maintaining effective internal controls;

(4)risks associated with managing growth organically and through acquisitions;

(5)risks associated with servicing our debt, the potential impact on the value of our common stock from the conditional conversion features of our debt and the associated convertible note hedge transactions;

(6)legal liabilities, including intellectual property protection and infringement or the disclosure of personally identifiable information;

(7)the risks detailed from time to time within our filings with the Securities and Exchange Commission (the “SEC”);

(8)uncertainties associated with the proposed merger of Perficient with an affiliate of BPEA Private Equity Fund VIII (“EQT Asia”);

(9)the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the proposed merger;

(10)risks related to disruption of management time from ongoing business operations due to the proposed merger;

(11)the risk that the conditions to the proposed merger may not be satisfied in a timely manner or at all;

(12)the risk of any unexpected costs or expenses resulting from the proposed merger;

(13)restrictions imposed on our business during the pendency of the proposed merger;

(14)the risk of any litigation relating to the proposed merger; and

(15)the risk that the proposed merger and its announcement could have an adverse effect on the ability of Perficient to retain and hire key personnel and to maintain relationships with customers, vendors, partners, employees, stockholders and other business relationships and on its operating results and business generally.

This discussion is not exhaustive, but is designed to highlight important factors that may impact our forward-looking statements. Because the factors referred to above, as well as the statements included under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, including documents incorporated by reference therein and herein, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement made by us or on our behalf, you should not place undue reliance on any forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform such statements to actual results.

1

All forward-looking statements, express or implied, included in this report and the documents we incorporate by reference that are attributable to Perficient, Inc. and its subsidiaries (collectively, “we,” “us,” “Perficient,” or the “Company”) are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that the Company or any persons acting on our behalf may issue.

2

Item 1. Financial Statements

Perficient, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share information)

 

	March 31, 2024 (unaudited)		December 31, 2023
Assets
Current assets:
Cash, cash equivalents and restricted cash	$	118,193	$	128,886
Accounts receivable, net	171,838		178,998
Prepaid expenses	5,758		5,638
Other current assets	13,548		12,431
Total current assets	309,337		325,953
Property and equipment, net	10,375		11,996
Operating lease right-of-use assets	22,812		21,786
Goodwill	613,790		581,387
Intangible assets, net	75,430		71,118
Other non-current assets	53,936		52,364
Total assets	$	1,085,680	$	1,064,604
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	13,919	$	18,688
Other current liabilities	60,104		59,784
Total current liabilities	74,023		78,472
Long-term debt, net	397,446		396,874
Operating lease liabilities	17,915		16,446
Other non-current liabilities	42,566		42,189
Total liabilities	$	531,950	$	533,981
Stockholders’ equity:
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of March 31, 2024 and December 31, 2023)	$	—	$	—
Common stock (par value $0.001 per share; 100,000,000 authorized; 53,833,315 shares issued and 34,455,848 shares outstanding as of March 31, 2024; 53,465,127 shares issued and 34,174,200 shares outstanding as of December 31, 2023)	54		53
Additional paid-in capital	448,855		432,160
Accumulated other comprehensive loss	(6,336)		(5,461)
Treasury stock, at cost (19,377,467 shares as of March 31, 2024; 19,290,927 shares as of December 31, 2023)	(377,594)		(373,325)
Retained earnings	488,751		477,196
Total stockholders’ equity	553,730		530,623
Total liabilities and stockholders’ equity	$	1,085,680	$	1,064,604

See accompanying notes to interim unaudited condensed consolidated financial statements.

3

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share information)

	Three Months Ended
	March 31,
	2024		2023
Revenues	$	215,304	$	231,408
Cost of revenues (exclusive of depreciation and amortization, shown separately below)
Cost of services	139,599		141,688
Stock compensation	2,507		2,524
Total cost of revenues	142,106		144,212
Selling, general and administrative	39,243		39,604
Stock compensation	9,923		4,316
Total selling, general and administrative	49,166		43,920
Depreciation	2,011		2,305
Amortization	4,886		5,817
Acquisition costs	1,393		79
Adjustment to fair value of contingent consideration	41		(2,026)
Income from operations	15,701		37,101
Net interest (income) expense	(767)		505
Net other (income) expense	(45)		75
Income before income taxes	16,513		36,521
Provision for income taxes	4,958		9,721
Net income	$	11,555	$	26,800
Basic net income per share	$	0.34	$	0.79
Diluted net income per share	$	0.33	$	0.75
Shares used in computing basic net income per share	34,149		33,914
Shares used in computing diluted net income per share	36,905		36,697

See accompanying notes to interim unaudited condensed consolidated financial statements.

4

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Comprehensive Income

(in thousands)

	Three Months Ended
	March 31,
	2024		2023
Net income	$	11,555	$	26,800
Other comprehensive (loss) income:
Foreign currency translation adjustment, net of tax	(875)		1,772
Comprehensive income	$	10,680	$	28,572

See accompanying notes to interim unaudited condensed consolidated financial statements.

5

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

		Three Months Ended
		March 31,
		2024		2023
Common Stock
Beginning of period		$	53	$	53
	Stock compensation related to restricted stock vesting and retirement savings plan contributions	1		—
End of period		54		53
Additional Paid-in Capital
Beginning of period		432,160		403,866
	Proceeds from the sales of stock through the Employee Stock Purchase Plan	197		240
	Stock compensation related to restricted stock vesting and retirement savings plan contributions	12,506		6,853
	Issuance of stock in conjunction with acquisition including stock attributed to future compensation	3,992		—
End of period		448,855		410,959
Accumulated Other Comprehensive Loss
Beginning of period		(5,461)		(17,519)
	Foreign currency translation adjustment	(875)		1,772
End of period		(6,336)		(15,747)
Treasury Stock
Beginning of period		(373,325)		(354,536)
	Purchases of treasury stock and buyback of shares for taxes	(4,269)		(7,449)
	Stock reacquired for escrow claim	—		(164)
End of period		(377,594)		(362,149)
Retained Earnings
Beginning of period		477,196		378,263
	Net income	11,555		26,800
End of period		488,751		405,063
Total Stockholders’ Equity		$	553,730	$	438,179

		Three Months Ended
		March 31,
Common Stock, shares		2024	2023
Beginning of period		34,174	34,072
	Sales of stock through the Employee Stock Purchase Plan	3	4
	Stock compensation related to restricted stock vesting, retirement savings plan contributions and other	298	191
	Purchases of treasury stock, buyback of shares for taxes and other	(87)	(106)
	Issuance of stock in conjunction with acquisition including stock attributed to future compensation	68	—
	Stock reacquired for escrow claim	—	(2)
End of period		34,456	34,159

See accompanying notes to interim unaudited condensed consolidated financial statements.

6

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows 

 (in thousands)

	Three Months Ended March 31,
	2024		2023
Operating Activities
Net income	$	11,555	$	26,800
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	2,011		2,305
Amortization	4,886		5,817
Deferred income taxes	(796)		(1,885)
Non-cash stock compensation and retirement savings plan contributions	12,222		6,674
Amortization of debt issuance costs	631		608
Adjustment to fair value of contingent consideration for purchase of businesses	41		(2,026)
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	10,928		18,784
Other assets	(1,360)		5,705
Accounts payable	(4,824)		(9,909)
Other liabilities	(3,323)		(11,542)
Net cash provided by operating activities	31,971		41,331
Investing Activities
Purchase of property and equipment	(319)		(1,015)
Capitalization of internally developed software costs	(341)		(328)
Purchase of businesses, net of cash acquired	(33,157)		28
Net cash used in investing activities	(33,817)		(1,315)
Financing Activities
Payment for credit facility financing fees	—		(683)
Payment of contingent consideration for purchase of business	(4,516)		(21,530)
Proceeds from the sale of stock through the Employee Stock Purchase Plan	197		240
Purchases of treasury stock	—		(2,395)
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(4,269)		(5,054)
Net cash used in financing activities	(8,588)		(29,422)
Effect of exchange rate on cash, cash equivalents and restricted cash	(259)		271
Change in cash, cash equivalents and restricted cash	(10,693)		10,865
Cash, cash equivalents and restricted cash at beginning of period	128,886		30,130
Cash, cash equivalents and restricted cash at end of period	$	118,193	$	40,995

See accompanying notes to interim unaudited condensed consolidated financial statements.

7

	Three Months Ended March 31,
	2024		2023
Supplemental Disclosures:
Cash paid for income taxes	$	2,770	$	1,553
Cash paid for interest	$	278	$	136
Non-Cash Investing Activity:
Stock issued for purchase of businesses (stock reacquired for escrow claim)	$	3,809	$	(164)

See accompanying notes to interim unaudited condensed consolidated financial statements.

8

PERFICIENT, INC.

NOTES TO INTERIM UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

1. Basis of Presentation

The accompanying interim unaudited condensed consolidated financial statements of Perficient, Inc. and its subsidiaries (collectively, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Accordingly, certain note disclosures have been condensed or omitted. In the opinion of management, the interim unaudited condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Certain reclassifications were made to prior year amounts to conform to the 2024 presentation.

2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements.

There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2023 that have had a material impact on the Company’s condensed consolidated financial statements and related notes.

3. Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) Improvements To Reportable Segment Disclosures, which requires additional disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The Company will adopt this ASU retrospectively for the annual period beginning on January 1, 2024 and for interim periods beginning on January 1, 2025.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements To Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company expects to adopt this ASU prospectively for the annual period beginning on January 1, 2025.

4. Revenue

The Company’s revenues consist of services and software and hardware sales. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of services or goods are transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services or goods.

Services Revenues

Services revenues are primarily comprised of professional services that include developing, implementing, automating and extending business processes, technology infrastructure, and software applications. The Company’s professional services span multiple industries, platforms and solutions; however, the Company has remained relatively diversified and does not believe that it has significant revenue concentration within any single industry, platform or solution.

9

Professional services revenues are recognized over time as services are rendered. Most projects are performed on a time and materials basis, while a portion of revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material contracts, revenues are generally recognized and invoiced by multiplying the number of hours expended in the performance of the contract by the hourly rates. For fixed fee contracts, revenues are generally recognized and invoiced by multiplying the fixed rate per time period established in the contract by the number of time periods elapsed. For fixed fee percent complete contracts, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours, and the client is invoiced according to the agreed-upon schedule detailing the amount and timing of payments in the contract.

Clients are typically billed monthly for services provided during that month but can be billed on a more or less frequent basis as determined by the contract. If the time is worked and approved at the end of a fiscal period and the invoice has not yet been sent to the client, the amount is recorded as revenue once the Company verifies all other revenue recognition criteria have been met, and the amount is classified as a receivable as the right to consideration is unconditional at that point. Amounts invoiced in excess of revenues recognized are contract liabilities, which are classified as deferred revenues in the Unaudited Condensed Consolidated Balance Sheet. The term between invoicing and payment due date is not significant. Contracts for professional services provide for a general right, to the client or the Company, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract. Certain contracts may include volume discounts or holdbacks, which are accounted for as variable consideration, but are not typically significant. The Company estimates variable consideration based on historical experience and forecasted sales and includes the variable consideration in the transaction price.

Other services revenues are comprised of hosting fees, partner referral fees, maintenance agreements, training and internally developed software-as-a-service (“SaaS”) sales. Revenues from hosting fees, maintenance agreements, training and internally developed SaaS sales are generally recognized over time using a time-based measure of progress as services are rendered. Partner referral fees are recorded at a point in time upon meeting specified requirements to earn the respective fee.

On many professional service projects, the Company is also reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract and are invoiced as the expenses are incurred. The Company structures its professional services arrangements to recover the cost of reimbursable expenses without a markup.

Software and Hardware Revenues

Software and hardware revenues are comprised of third-party software and hardware resales, in which the Company is considered the agent, and sales of internally developed software, in which the Company is considered the principal. Third-party software and hardware revenues are recognized and invoiced when the Company fulfills its obligation to arrange the sale, which occurs when the purchase order with the vendor is executed and the customer has access to the software or the hardware has been shipped to the customer. Internally developed software revenues are recognized and invoiced when control is transferred to the customer, which occurs when the software has been made available to the customer and the license term has commenced. Revenues from third-party software and hardware sales are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. There are no significant cancellation or termination-type provisions for the Company’s software and hardware sales, and the term between invoicing and payment due date is not significant.

Revenues are presented net of taxes assessed by governmental authorities. Sales taxes are generally collected and subsequently remitted on all software and hardware sales and certain services transactions as appropriate.

Arrangements with Multiple Performance Obligations

Arrangements with clients may contain multiple promises such as delivery of software, hardware, professional services or post-contract support services. These promises are accounted for as separate performance obligations if they are distinct. For arrangements with clients that contain multiple performance obligations, the transaction price is allocated to the separate performance obligations based on estimated relative standalone selling price, which is estimated by the expected cost plus a margin approach, taking into consideration market conditions and competitive factors. Because contracts that contain multiple performance obligations are typically short term due to the contract cancellation provisions, the allocation of the transaction price to the separate performance obligations is not considered a significant estimate.

Contract Costs

10

In accordance with the terms of the Company’s sales commission plan, commissions are not earned until the related revenue is recognized. Therefore, sales commissions are expensed as they are earned. Certain sales incentives are accrued based on achievement of specified bookings goals. For these incentives, the Company applies the practical expedient that allows the Company to expense the incentives as incurred because the amortization period would have been one year or less.

Deferred Revenue

The Company’s deferred revenue balance as of March 31, 2024 and December 31, 2023 was $3.3 million and $5.5 million, respectively. Substantially all of the December 31, 2023 deferred revenue balance was recognized in revenue during the three months ended March 31, 2024.

Transaction Price Allocated to Remaining Performance Obligations

Due to the ability of the client or the Company to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required), the majority of the Company’s contracts have a term of less than one year. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original maturity date of one year or less or time and materials contracts for which the Company has the right to invoice for services performed. Revenue related to unsatisfied performance obligations for remaining contracts as of March 31, 2024 was immaterial.

Disaggregation of Revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):

	Three Months Ended March 31,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	154.2	$	—	$	154.2	$	175.5	$	—	$	175.5
Fixed fee percent complete contracts	14.9		—		14.9		14.8		—		14.8
Fixed fee contracts	40.7		—		40.7		36.3		—		36.3
Reimbursable expenses	3.6		—		3.6		2.5		—		2.5
Total professional services fees	213.4		—		213.4		229.1		—		229.1
Other services revenue*	1.2		0.3		1.5		1.4		0.3		1.7
Total services	214.6		0.3		214.9		230.5		0.3		230.8
Software and hardware	—		0.4		0.4		—		0.6		0.6
Total revenues	$	214.6	$	0.7	$	215.3	$	230.5	$	0.9	$	231.4

*Other services revenue primarily consists of hosting fees, maintenance, training, internally developed SaaS revenue and partner referral fees.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):

	Three Months Ended March 31,
	2024		2023
United States	$	205.6	$	223.5
Other countries	9.7		7.9
Total revenues	$	215.3	$	231.4

5. Stock-Based Compensation

Stock-based compensation is accounted for in accordance with ASC Topic 718, Compensation – Stock Compensation. Under this guidance, the Company recognizes share-based compensation ratably using the straight-line attribution method over the requisite service period, which is generally three years. The fair value of restricted stock awards is based on the value of the Company’s common stock on the date of the grant.

11

The Company’s Third Amended and Restated 2012 Long Term Incentive Plan (as amended, the “Incentive Plan”) allows for the granting of various types of stock awards, not to exceed a total of 8.5 million shares, to eligible individuals. The Compensation Committee of the Board of Directors administers the Incentive Plan and determines the terms of all stock awards made under the Incentive Plan. As of March 31, 2024, there were 1.8 million shares of common stock available for issuance under the Incentive Plan.

Stock-based compensation cost recognized for the three months ended March 31, 2024 was $12.4 million, which included $1.0 million of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $3.7 million for the three months ended March 31, 2024. Stock-based compensation cost recognized for the three months ended March 31, 2023 was $6.8 million, which included $1.1 million of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $1.8 million for the three months ended March 31, 2023.

On February 23, 2024, Jeffrey S. Davis resigned his employee position as Executive Chairman of the Company, effective as of March 1, 2024. Mr. Davis is continuing as the non-executive Chairman of the Board of Directors. In connection with Mr. Davis’s resignation, the Board of Directors approved an amendment to certain existing restricted stock award agreements. Due to the resignation of Mr. Davis as Executive Chairman of the Company and the related restricted stock award amendment, the incremental share based compensation expense recorded during the three months ended March 31, 2024 was approximately $5.6 million.

Restricted Stock Awards (“RSAs”)

Restricted stock activity for the three months ended March 31, 2024 was as follows (shares in thousands):

 

	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.04
Awards vested	(194)	73.93
Awards forfeited	(17)	68.42
Restricted stock awards outstanding at March 31, 2024	698	$	69.50

As of March 31, 2024, there was $37.0 million of total unrecognized compensation cost related to non-vested RSAs with a weighted-average remaining life of two years.    

Performance Stock Awards (“PSAs”)

In connection with the announcement of Thomas J. Hogan’s promotion to Chief Executive Officer, the Company granted a PSA of 10,842 shares to Mr. Hogan on July 25, 2023 under the Incentive Plan with terms determined at the discretion of the Compensation Committee of the Board of Directors. The actual number of shares subject to the PSA that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Nasdaq Composite Index over a three-year period. The grant date fair value of $80.90 per share was based on a Monte Carlo simulation model as of the date of the award. PSA related stock-based compensation cost recognized for the three months ended March 31, 2024 was $0.1 million. As of March 31, 2024, there was $0.7 million of total unrecognized compensation cost related to unvested PSAs, expected to be recognized over a period of three years.

12

6. Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):

	Three Months Ended
	March 31,
	2024		2023
Net income, basic	$	11,555	$	26,800
Add back interest expense on convertible notes, net of tax	534		560
Net income, diluted	$	12,089	$	27,360
Basic:
Weighted-average shares of common stock outstanding	34,149		33,914
Shares used in computing basic net income per share	34,149		33,914
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	177		154
Shares issuable for acquisition consideration (1)	149		199
Shares issuable for conversion of convertible senior notes	2,430		2,430
Shares used in computing diluted net income per share	36,905		36,697
Basic net income per share	$	0.34	$	0.79
Diluted net income per share	$	0.33	$	0.75

(1)For the three months ended March 31, 2024, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Purchase Agreement with Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (collectively, “Talos”); (iii) the Stock Purchase Agreement with the shareholders of Izmul S.A. (“Overactive”); (iv) the Purchase Agreement with the shareholders of Ameex Technologies Corporation (“Ameex”); and (v) the Purchase Agreement with the shareholders of SMEDIX, Inc. (“SMEDIX”), as part of the consideration. For the three months ended March 31, 2023, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon; (ii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); (iii) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”); (iv) the Purchase Agreement with Talos; (v) the Stock Purchase Agreement with the shareholders of Overactive; (vi) the Stock Purchase Agreement with the shareholders of Inflection Point Systems, Inc.; and (vii) the Purchase Agreement with the shareholders of Ameex, as part of the consideration.

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):

	Three Months Ended
	March 31,
	2024	2023
Restricted stock and performance stock awards subject to vesting	109	276
Warrants related to the issuance of convertible senior notes	2,431	2,431
Total anti-dilutive securities	2,540	2,707

See Note 11, Long-term Debt for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of Company common stock through a stock repurchase program expiring December 31, 2024. The program could be suspended or discontinued at any time,

13

based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately $291.1 million (16.5 million shares) of outstanding common stock through March 31, 2024.

7. Balance Sheet Components

	March 31, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	97.6	$	119.9
Unbilled revenues, net	74.2		59.1
Total	$	171.8	$	179.0

Other current assets:
Miscellaneous receivables	$	3.5	$	3.1
Contractual commitment asset	3.4		3.0
Income tax receivable	3.2		2.7
Other current assets	3.4		3.6
Total	$	13.5	$	12.4

Property and equipment:
Computer hardware (useful life of 3 years)	$	25.5	$	26.7
Software (useful life of 1 to 7 years)	9.1		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.8		7.8
Less: Accumulated depreciation	(36.3)		(36.2)
Total	$	10.4	$	12.0

Other non-current assets:
Non-current unbilled revenue	$	1.3	$	2.2
Company owned life insurance asset	13.9		12.6
Long term deposits	1.9		1.8
Credit facility deferred finance fees, net	1.0		1.0
Other non-current assets	13.6		13.2
Deferred income taxes	22.2		21.6
Total	$	53.9	$	52.4

Other current liabilities:
Estimated fair value of contingent consideration liability (Note 9)	$	6.4	$	4.5
Accrued variable compensation	13.1		15.9
Current operating lease liabilities	6.4		7.0
Payroll related costs	11.2		11.1
Deferred revenues	3.3		5.5
Income tax payable	4.7		1.5
Other current liabilities	5.8		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	1.8		1.3
Accrued IT expenses	5.1		5.0
Total	$	60.1	$	59.8

14

	March 31, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	5.4	$	5.9
Reserve for uncertain tax positions	18.4		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	4.6		5.0
Non-current software accrual	1.7		2.6
Total	$	42.6	$	42.2

8. Allowance for Credit Losses

In accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company evaluates its allowance based on expected losses rather than incurred losses, which is known as the current expected credit loss model. The allowance is determined using the loss rate approach and is measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts.

Activity in the allowance for credit losses is summarized as follows (in millions):

	Three Months Ended March 31,
	2024		2023
Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	(0.1)		—
Other (1)	(0.5)		(1.2)
Balance at March 31	$	1.9	$	4.6

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

9. Business Combinations

2024 Acquisition

On January 16, 2024, the Company acquired all of the outstanding capital stock of SMEDIX. SEMDIX is a healthcare software engineering firm headquartered in San Diego, California, with offshore operations located in Cluj-Napoca, Romania. The acquisition of SMEDIX continued to strengthen our healthcare industry digital capabilities, enhance our global delivery capacity, and expand further within Eastern Europe. SMEDIX added more than 175 professionals and strategic client relationships focused in the biomedical and healthcare industry. The Company’s total allocable purchase price consideration was $43.6 million, net of cash acquired. The Company incurred approximately $1.7 million in transaction costs, which were expensed when incurred. The amount of goodwill deductible for tax purposes is $33.6 million.

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):

	SMEDIX
Cash, net of cash acquired	$	33.2
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.6

(1)Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the closing date of the acquisition.

15

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of March 31, 2024, the fair value of the contingent consideration was $6.4 million.

The Company has estimated the preliminary allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

	SMEDIX
Acquired tangible assets	$	4.9
Identified intangible assets	8.9
Liabilities assumed	(3.1)
Goodwill	32.9
Total allocable purchase price consideration	$	43.6

The following table presents details of the intangible assets acquired during the three months ended March 31, 2024.

	Weighted Average Useful Life	Estimated Useful Life	SMEDIX
Customer relationships	6 years	6 years	$	7.0
Customer backlog	1 year	1 year	1.7
Non-compete agreements	5 years	5 years	0.1
Trade name	1 year	1 year	0.1
Total acquired intangible assets			$	8.9

The above purchase price accounting estimates for SMEDIX are pending finalization of certain acquired tangible and intangible assets, contingent consideration valuation, and a net working capital settlement that is subject to final adjustment as the Company evaluates information during the measurement period.

Pro-forma Results of Operations

Pro-forma results of operations have not been presented for SMEDIX because the effect of the acquisition on the Company's condensed consolidated financial statements was not material.

10. Goodwill and Intangible Assets

Goodwill represents the excess purchase price over the fair value of net assets acquired, or net liabilities assumed, in a business combination. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, the Company performs an annual impairment review in the fourth quarter and more frequently if events or changes in circumstances indicate that goodwill might be impaired. There was no indication that goodwill became impaired for the three months ended March 31, 2024.

Other intangible assets include customer relationships, non-compete arrangements, trade names, customer backlog, and developed software, which are being amortized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives range from less than one year to ten years. Amortization of customer relationships, non-compete arrangements, trade names, customer backlog, and developed software is considered an operating expense and is included in “Amortization” in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in a lack of recoverability or revised useful life. There was no indication that other intangible assets became impaired for the three months ended March 31, 2024.

16

Goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 are as follows (in millions):

 

Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.9
Effect of foreign currency translation adjustments	(0.5)
Balance at March 31, 2024	$	613.8

Intangible Assets with Definite Lives

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):

	March 31, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	122.9	$	(51.1)	$	71.8	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.6)		0.6		1.1		(0.6)		0.5
Customer backlog	1.7		(0.4)		1.3		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	8.8		(7.2)		1.6		8.5		(6.7)		1.8
Total	$	135.5	$	(60.1)	$	75.4	$	126.5	$	(55.4)	$	71.1

The estimated useful lives of identifiable intangible assets are as follows:

 

Customer relationships	5 - 10 years
Non-compete agreements	4 - 5 years
Customer backlog	1 year
Trade name	1 year
Developed software	1 - 7 years

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):

2024 remaining	$	13.9
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

11. Long-term Debt

Revolving Credit Facility

On March 29, 2023, the Company amended and restated its existing credit agreement by entering into a Second Amended and Restated Credit Agreement (the “2023 Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding

17

amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of March 31, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred finance fees during the three months ended March 31, 2023.

The 2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of March 31, 2024, there were no outstanding letters of credit. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the 2023 Credit Agreement bear interest at the Company’s option of the prime rate (8.50% on March 31, 2024) plus a margin ranging from 0.00% to 1.00% or one month Secured Overnight Financing Rate (“SOFR”) (5.34% on March 31, 2024) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of March 31, 2024, the Company had $300.0 million of unused borrowing capacity.

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At March 31, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

On November 9, 2021, the Company issued $380.0 million aggregate principal amount of 0.125% Convertible Senior Notes Due 2026 (the “2026 Notes”) in a private placement to qualified institutional buyers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The 2026 Notes bear interest at a rate of 0.125% per year. Interest is payable in cash on May 15 and November 15 of each year, with the first payment made on May 15, 2022. The 2026 Notes mature on November 15, 2026 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 5.2100 shares of the Company’s common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $191.94 per share of common stock. After consideration of the 2026 Notes Hedges and 2026 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $295.29 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2026 Notes (the “2026 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2026 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2026 Notes in cash upon conversion.

Convertible Senior Notes due 2025

On August 14, 2020, the Company issued $230.0 million aggregate principal amount of 1.250% Convertible Senior Notes Due 2025 (the “2025 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The 2025 Notes bear interest at a rate of 1.250% per year. Interest is payable in cash on February 1 and August 1 of each year. The 2025 Notes mature on August 1, 2025 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 19.3538 shares of the Company’s common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $51.67 per share of common stock. After consideration of the 2025 Notes Hedges and 2025 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $81.05 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2025 Notes (the “2025 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2025 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2025 Notes in cash upon conversion.

Other Terms of the Notes

The 2025 Notes and 2026 Notes may be converted at the holder’s option prior to the close of business on the business day immediately preceding August 1, 2025 for the 2025 Notes and November 15, 2026 for the 2026 Notes, but only under the following circumstances:

18

•during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 for the 2025 Notes and December 31, 2021 for the 2026 Notes, if the last reported sale price per share of the Company’s common stock exceeds 130% of the applicable conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

•during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the applicable conversion rate on such trading day;

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

•at any time from, and including, February 3, 2025 for 2025 Notes and May 15, 2026 for 2026 Notes, until the close of business on the second scheduled trading day immediately before the maturity date for the 2025 Notes and 2026 Notes.

The Company may not redeem the 2025 Notes and 2026 Notes at its option before maturity. If a “fundamental change” (as defined in the 2025 Indenture and 2026 Indenture) occurs, then, except as described in the 2025 Indenture and 2026 Indenture, noteholders may require the Company to repurchase their 2025 Notes and 2026 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes and 2026 Notes to be repurchased, plus accrued and unpaid interest, if any.

As of March 31, 2024, none of the conditions permitting holders to convert their 2025 Notes and 2026 Notes had been satisfied and no shares of the Company’s common stock had been issued in connection with any conversions of the 2025 Notes and 2026 Notes during the three months ended March 31, 2024. Based on the closing price of the Company's common stock of $56.29 per share on March 31, 2024, the conversion value of the 2026 Notes was less than the principal amount of the 2026 Notes outstanding on a per note basis, and the conversion value of the 2025 Notes was greater than the principal amount of the 2025 Notes outstanding on a per note basis.

The 2025 Notes and 2026 Notes consisted of the following (in millions):

	March 31, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.6)		(0.2)
Net carrying amount	$	374.4	$	23.1

	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three months ended March 31, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	0.6		0.6
Total interest expense recognized	$	0.7	$	0.7

19

2025 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	—		—
Total interest expense recognized	$	0.1	$	0.1

Convertible Notes Hedges

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company entered into privately negotiated convertible note hedge transactions (the “2026 Notes Hedges” and the “2025 Notes Hedges”), and together, the “Notes Hedges”) with certain of the initial purchasers or their respective affiliates and/or other financial institutions (the “Option Counterparties”). As of March 31, 2024, the 2026 Notes Hedges provide the Company with the option to acquire, on a net settlement basis, approximately 2.0 million shares of common stock at a strike price of $191.94, which is equal to the number of shares of common stock that notionally underlie the 2026 Notes and correspond to the conversion price of the 2026 Notes. As of March 31, 2024, the 2025 Notes Hedges provided the Company with the option to acquire, on a net settlement basis, approximately 0.5 million shares of common stock at a strike price of $51.67, which is equal to the number of shares of common stock that notionally underlie the 2025 Notes and correspond to the conversion price of the 2025 Notes. If the Company elects cash settlement and exercises the Notes Hedges, the aggregate amount of cash received from the Option Counterparties will cover the aggregate amount of cash that the Company would be required to pay to the holders of the Notes, less the principal amount thereof. The Notes Hedges do not meet the criteria for separate accounting as a derivative as they are indexed to the Company’s stock and are accounted for as freestanding financial instruments.

Convertible Notes Warrants

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company also sold net-share-settled warrants (the “2026 Notes Warrants” and the “2025 Notes Warrants,” respectively, and together, the “Notes Warrants”) in privately negotiated transactions with the Option Counterparties. The strike price of the 2026 Notes Warrants and 2025 Notes Warrants was approximately $295.29 and $81.05 per share, respectively, and is subject to certain adjustments under the terms of their respective Notes Warrants. As a result of the 2026 Notes Warrants and 2025 Notes Warrants and related transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price for any fiscal quarter is over $295.29 for the 2026 Notes Warrants and $81.05 for the 2025 Notes Warrants. The 2026 Notes Warrants and the 2025 Notes Warrants expire over a period of 80 trading days commencing on February 15, 2027 and over a period of 100 trading days commencing on November 1, 2025, respectively, and may be settled in net shares of common stock or net cash at the Company’s election. As of March 31, 2024, 2.0 million warrant shares and 0.5 million warrant shares were outstanding for the 2026 Notes Warrants and 2025 Notes Warrants, respectively.

12. Income Taxes

The Company's effective tax rate was 30.0% for the three months ended March 31, 2024, which was higher than the U.S. statutory rate of 21.0% primarily due to state taxes, share-based compensation and Section 162(m) compensation limitations.

The Company’s effective tax rate was 26.6% for the three months ended March 31, 2023, which was higher than the U.S. statutory rate of 21.0% primarily due to state taxes and foreign operations.

13. Derivatives

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company’s derivative financial instruments consist of non-deliverable and deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

20

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net loss of $0.2 million during the three months ended March 31, 2024. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net gain of $0.4 million during the three months ended March 31, 2023. Gains and losses on these contracts are recorded in net other expense (income) and net interest expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	28.2	$	26.2
Total derivatives not designated as hedges	$	28.2	$	26.2

14. Fair Value Measurements

The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

The carrying value of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments.

All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of March 31, 2024 and December 31, 2023, $54.5 million and $45.3 million, respectively of the Company’s cash, cash equivalents and restricted cash balance related to Level 1 investments.

The Company has a deferred compensation plan, which is funded through Company owned life insurance (“COLI”) policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was $13.9 million and $12.6 million as of March 31, 2024 and December 31, 2023, respectively.

The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of March 31, 2024 and December 31, 2023 were immaterial.

21

The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 7, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of March 31, 2024 and December 31, 2023.

The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease.

The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of March 31, 2024 and December 31, 2023 was $328.9 million and $316.1 million, respectively. The approximate fair value of the 2025 Notes as of March 31, 2024 and December 31, 2023 was $28.3 million and $32.4 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

15. Leases

The Company leases office space under various operating lease agreements, which have remaining lease terms of less than one year to seven years. Operating leases are included in operating lease right-of-use assets, other current liabilities, and operating lease liabilities on the consolidated balance sheet. Operating lease expense for the three months ended March 31, 2024 and 2023 were $3.0 million and $3.3 million, respectively.

Supplemental balance sheet information related to leases was as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.4	$	7.0
Operating lease liabilities	17.9		16.4
Total	$	24.3	$	23.4

Future minimum lease payments as of March 31, 2024 were as follows (in millions):

	March 31, 2024 (unaudited)
2024 remaining	$	5.4
2025	6.9
2026	4.8
2027	4.5
2028	3.4
Thereafter	2.0
Total future lease payments	27.0
Less implied interest	(2.7)
Total	$	24.3

22

16. Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities.

17. Subsequent Event

On May 5, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Plano HoldCo, Inc., a Delaware corporation (“Parent”), and Plano BidCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Parent and Merger Sub are affiliates of EQT Asia. Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the “Merger” and, collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). Under the terms of the Merger Agreement, the Company’s stockholders will receive $76.00 in cash per share of Company common stock outstanding as of the closing of the Merger.

Consummation of the Merger is subject to various conditions, including, among others, customary conditions relating to the adoption of the Merger Agreement by the holders of a majority of the Company’s outstanding common stock, the expiration or termination of any applicable waiting periods under the Hart-Scott-Rodino Act, conclusion of any review or investigation of the Transactions by the Committee on Foreign Investment in the United States, the receipt of certain foreign regulatory approvals and other customary conditions for a transaction of this type, such as the absence of any legal restraint prohibiting the consummation of the Transactions and the absence of any Company Material Adverse Effect (as defined in the Merger Agreement). Consummation of the Merger is not subject to any financing condition, and is expected to occur by the end of 2024.

The Company expects to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger Agreement. If the Merger Agreement is terminated under specified circumstances, Parent may be required to pay a termination fee of $162.6 million to the Company.

23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statements made in this Form 10-Q, including without limitation this Management’s Discussion and Analysis of Financial Condition and Results of Operations, other than statements of historical information, are forward looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements may sometimes be identified by such words as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. We believe that it is important to communicate our future expectations to investors. However, these forward-looking statements involve many risks and uncertainties. Our actual results could differ materially from those indicated in such forward-looking statements as a result of certain factors, including but not limited to, those set forth under “Risk Factors” in our Annual Report on Form 10-K previously filed with the SEC and elsewhere in this Form 10-Q. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform these statements to actual results. For additional information, see the “Special Note Regarding Forward-Looking Statements” contained in this Form 10-Q.

Overview

Perficient is a global digital consultancy transforming how the world’s biggest brands connect with customers and grow their businesses. We help clients, primarily focused in North America, gain competitive advantage by using digital technology to: make their businesses more responsive to market opportunities; strengthen relationships with customers, suppliers, and partners; improve productivity; and reduce information technology costs. With unparalleled strategy, creative and technology capabilities, across industries, our end-to-end digital consulting services help our clients drive faster speed-to-market capabilities and stronger, more compelling experiences for consumers. We go to market with six primary service categories – strategy and transformation, data and intelligence, platforms and technology, customer experience and digital marketing, innovation and product development, and optimized global delivery. Within each service category, and collectively, we deliver a deep and broad portfolio of solutions that enable our clients to operate a real-time enterprise that dynamically adapts business processes and the systems that support them to meet the changing demands of a global and competitive marketplace.

Services Revenues

Services revenues are derived from professional services that include developing, implementing, integrating, automating and extending business processes, technology infrastructure, and software applications. Professional services revenues are recognized over time as services are rendered. Most of our projects are performed on a time and materials basis, while a portion of our revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material projects, revenues are recognized and billed by multiplying the number of hours our professionals expend in the performance of the project by the hourly rates. For fixed fee contracts, revenues are recognized and billed by multiplying the established fixed rate per time period by the number of time periods elapsed. For fixed fee percent complete projects, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours. Fixed fee percent complete engagements represented 7% of our services revenues for the three months ended March 31, 2024, and 6% for the three months ended March 31, 2023, respectively. On most projects, we are reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract. The aggregate amount of reimbursed expenses will fluctuate depending on the location of our clients, the total number of our projects that require travel, and whether our arrangements with our clients provide for the reimbursement of such expenses. In conjunction with services provided, we occasionally receive referral fees under partner programs. These referral fees are recognized at a point in time when earned and recorded within services revenues.

Software and Hardware Revenues

Software and hardware revenues are derived from sales of third-party software and hardware resales, in which we are considered the agent, and sales of internally developed software, in which we are considered the principal. Revenues from sales of third-party software and hardware are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. Software and hardware revenues are expected to fluctuate depending on our clients’ demand for these products.

There are no significant cancellation or termination-type provisions for our software and hardware sales. Contracts for our professional services provide for a general right, to the client or us, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract.

24

Cost of Revenues

Cost of revenues consists of cost of services, primarily related to cash and non-cash compensation and benefits (including bonuses and non-cash compensation related to equity awards), costs associated with subcontractors, reimbursable expenses and other project-related expenses. Cost of revenues does not include depreciation of assets used in the production of revenues which are primarily personal computers, servers, and other information technology related equipment. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, sales of third-party software and hardware are presented on a net basis, and as such, third-party software and hardware costs are not presented within cost of revenues.

Our cost of services as a percentage of services revenues is affected by the utilization rates of our professionals (defined as the percentage of our professionals’ time billed to clients divided by the total available hours in the respective period), the salaries we pay our professionals, and the average billing rate we receive from our clients. If a project ends earlier than scheduled, we retain professionals in advance of receiving project assignments, or demand for our services declines, our utilization rate will decline and adversely affect our cost of services as a percentage of services revenues.

Selling, General, and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses are primarily composed of sales-related costs, general and administrative salaries, stock compensation expense, office costs, recruiting expense, variable compensation costs, marketing costs and other miscellaneous expenses.

Plans for Growth and Acquisitions

Our goal is to continue to build one of the leading information technology consulting firms by expanding our relationships with existing and new clients and through the continuation of our disciplined acquisition strategy. Our future growth plan includes expanding our business with a primary focus on customers in the United States, both organically and through acquisitions. We also intend to further leverage our existing offshore and nearshore capabilities to support our future growth and provide our clients flexible options for project delivery.

When analyzing revenue growth by base business compared to acquired companies in the Results of Operations section below, revenue attributable to base business includes revenue from an acquired company that has been owned for a full four quarters after the date of acquisition.

Results of Operations

Three months ended March 31, 2024 compared to three months ended March 31, 2023

Revenues. Total revenues decreased 7.0% to $215.3 million for the three months ended March 31, 2024 from $231.4 million for the three months ended March 31, 2023.

	Financial Results (in millions)						Explanation for Increases (Decreases) Over Prior Year Period (in millions)
	Three Months Ended March 31,				Total Decrease Over Prior Year Period		Increase Attributable to Revenue Delivered by Resources of Acquired Companies		Decrease Attributable to Revenue Delivered by Base Business Resources
	2024		2023
Services revenues	$	214.9	$	230.8	$	(15.9)	$	3.1	$	(19.0)
Software and hardware revenues	0.4		0.6		(0.2)		—		(0.2)
Total revenues	$	215.3	$	231.4	$	(16.1)	$	3.1	$	(19.2)

Services revenues decreased 6.9% to $214.9 million for the three months ended March 31, 2024 from $230.8 million for the three months ended March 31, 2023. The decrease in services revenues is primarily attributable to services revenues delivered by base business resources, which decreased $19.0 million, partially offset by an increase of $3.1 million in services

25

revenues delivered by resources of acquired companies. Services revenues delivered by base business resources decreased primarily due to reduced demand and mix shift to offshore.

Software and hardware revenues decreased to $0.4 million for the three months ended March 31, 2024 from $0.6 million for the three months ended March 31, 2023.

Cost of Revenues (exclusive of depreciation and amortization, discussed separately below). Cost of revenues decreased 1.5% to $142.1 million for the three months ended March 31, 2024 from $144.2 million for the three months ended March 31, 2023. Services costs as a percentage of services revenues increased to 66.1% for the three months ended March 31, 2024 from 62.5% for the three months ended March 31, 2023, primarily due to higher employee salaries and benefits as a percentage of services revenues.

Selling, General and Administrative. SG&A expenses increased to $49.2 million for the three months ended March 31, 2024 from $43.9 million for the three months ended March 31, 2023. SG&A expenses as a percentage of revenues were 22.8% and 19.0% for the three months ended March 31, 2024 and March 31, 2023, respectively. The increase in SG&A expenses was primarily due to a $5.6 million increase in stock compensation expense resulting from Jeffrey S. Davis’s resignation as Executive Chairman of the Company and certain amendments to his outstanding award agreements in connection with his resignation.

Depreciation. Depreciation expense decreased 12.8% to $2.0 million for the three months ended March 31, 2024 from $2.3 million for the three months ended March 31, 2023. Depreciation expense as a percentage of revenues was 0.9% and 1.0% for the three months ended March 31, 2024 and March 31, 2023, respectively.

Amortization. Amortization expense decreased 16.0% to $4.9 million for the three months ended March 31, 2024 from $5.8 million for the three months ended March 31, 2023. Amortization expense as a percentage of revenues was 2.3% for the three months ended March 31, 2024 and 2.5% for the three months ended March 31, 2023. Amortization expense decreased primarily due to certain intangibles becoming fully amortized.

Acquisition Costs. Acquisition-related costs increased to $1.4 million for the three months ended March 31, 2024 from $0.1 million for the three months ended March 31, 2023. Costs were incurred for legal, accounting, tax, investment bank and advisor fees, and valuation services performed by third parties in connection with merger and acquisition-related activities. Acquisition costs increased primarily due to the acquisition of SMEDIX, Inc. (“SMEDIX”) that closed in January 2024.

Adjustment to Fair Value of Contingent Consideration. An immaterial adjustment was recorded during the three months ended March 31, 2024 which represents accretion for the SMEDIX revenue and earnings-based contingent consideration liabilities. An adjustment of $2.0 million was recorded to decrease the liability during the three months ended March 31, 2023 which represents the net fair market value adjustment to Inflection Point Systems, Inc. (“Inflection Point”) revenue and earnings-based contingent consideration liabilities, net of accretion for Inflection Point and Ameex Technologies Corporation (“Ameex”).

Net Interest (Income) Expense. Net interest income was $0.8 million for the three months ended March 31, 2024. Net interest expense was $0.5 million for the three months ended March 31, 2023. The decrease in net interest expense was primarily due to a $1.3 million increase in interest income resulting from higher average cash balances and higher rates.

Provision for Income Taxes. We provide for federal, state and foreign income taxes at the applicable statutory rates adjusted for non-deductible expenses. Our effective tax rate of 30.0% for the three months ended March 31, 2024 is higher than our effective tax rate of 26.6% for the three months ended March 31, 2023. The increase in effective tax rate was primarily due to the above described increase in shared-based compensation compared to the prior year quarter.

Liquidity and Capital Resources

Selected measures of liquidity and capital resources are as follows (in millions):

	March 31, 2024		December 31, 2023
Cash, cash equivalents and restricted cash (1)	$	118.2	$	128.9
Working capital (including cash, cash equivalents and restricted cash) (2)	$	235.3	$	247.5
Amounts available under credit facility	$	300.0	$	300.0

26

(1) The balance at March 31, 2024 includes $23.6 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated. We currently do not plan or foresee a need to repatriate such funds. The balance also includes $1.8 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations. The balance at December 31, 2023 includes $20.6 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated and includes $1.8 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations. The Company’s restricted cash balance as of March 31, 2024 and December 31, 2023 was $0.2 million and $0.2 million, respectively.

(2) Working capital is total current assets less total current liabilities.

Net Cash Provided by Operating Activities

Net cash provided by operating activities for the three months ended March 31, 2024 was $32.0 million compared to net cash provided by operating activities of $41.3 million for the three months ended March 31, 2023. For the three months ended March 31, 2024, the primary components of operating cash flows were net income of $11.6 million, non-cash charges of $19.0 million and net operating asset reductions of $1.4 million. For the three months ended March 31, 2023, the primary components of operating cash flows were net income of $26.8 million, non-cash charges of $11.5 million and net operating asset reductions of $3.0 million.

Net Cash Used in Investing Activities

During the three months ended March 31, 2024, we used $0.7 million to purchase property and equipment and to develop software and $33.2 million for the acquisition of SMEDIX. During the three months ended March 31, 2023, we used $1.3 million to purchase property and equipment and to develop software.

Net Cash Used in Financing Activities

During the three months ended March 31, 2024, we used $4.3 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also used $4.5 million to settle contingent consideration for the purchase of Inflection Point and Ameex and received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.2 million. During the three months ended March 31, 2023, we used $2.4 million to repurchase shares of our common stock through the stock repurchase program and $5.1 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also used $0.7 million for credit facility financing fees, used $21.5 million to settle contingent consideration for the purchase of Talos and Overactive and received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.2 million.

Availability of Funds from Bank Line of Credit Facility

On March 29, 2023, the Company entered into the 2023 Credit Agreement with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of March 31, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred finance fees during the three months ended March 31, 2023.

The 2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of March 31, 2024, there were no outstanding letters of credit. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the 2023 Credit Agreement bear interest at the Company’s option of the prime rate (8.50% on March 31, 2024) plus a margin ranging from 0.00% to 1.00% or one month Secured Overnight Financing Rate (“SOFR”) (5.34% on March 31, 2024) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of March 31, 2024, the Company had $300.0 million of unused borrowing capacity.

At March 31, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

27

Stock Repurchase Program

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of Company common stock through a stock repurchase program expiring December 31, 2024. The program could be suspended or discontinued at any time based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately $291.1 million (16.5 million shares) of outstanding common stock through March 31, 2024.

From time to time, the Company establishes a written trading plan in accordance with Rule 10b5-1 of the Exchange Act, pursuant to which the Company makes a portion of its stock repurchases. Additional repurchases will be at times and in amounts as the Company deems appropriate and will be made through open market transactions in compliance with Rule 10b-18 of the Exchange Act, subject to market conditions, applicable legal requirements, and other factors.

Cash Requirements from Contractual Obligations

For the three months ended March 31, 2024, there were no material changes outside the ordinary course of business in lease obligations or contractual obligations. See Note 15, Leases, in the Notes to Interim Condensed Consolidated Financial Statements for further description of our contractual obligations.

As of March 31, 2024 (unaudited) and December 31, 2023, there were no balances outstanding under the 2023 Credit Agreement. Any balances outstanding under the 2023 Credit Agreement would be classified as “Long-term debt” within the Condensed Consolidated Balance Sheet and become due and payable no later than the final maturity date of March 29, 2028. As of March 31, 2024, there were $397.4 million of outstanding 2026 Notes and 2025 Notes, net of unamortized issuance costs, compared to $396.9 million as of December 31, 2023. The amounts are classified as “Long-term debt” within the Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023. The 2026 Notes will become due and payable no later than the final maturity date of November 15, 2026. The 2025 Notes will become due and payable no later than the final maturity date of August 1, 2025.

Conclusion

Of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheet as of March 31, 2024 (unaudited) of $118.2 million, $23.6 million was held by certain foreign subsidiaries and is considered to be indefinitely reinvested in those operations. The Company is able to fund its liquidity needs outside of these subsidiaries, primarily through cash flows generated by domestic operations and our credit facility. Therefore, the Company has no current plans to repatriate cash from these foreign subsidiaries in the foreseeable future. As of March 31, 2024, $1.8 million of the total cash, cash equivalents and restricted cash was held by the Company’s Chinese subsidiary, the earnings of which are not considered to be permanently reinvested and may be repatriated from time to time.

We believe that the currently available funds, access to capital from our credit facility, and cash flows generated from operations will be sufficient to meet our working capital requirements and other capital needs for the next 12 months.

Critical Accounting Policies

Our accounting policies are fully described in Note 2, Summary of Significant Accounting Policies, to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023. We believe our most critical accounting policies include revenue recognition, purchase accounting and related fair value measurements, convertible debt, and income taxes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks related to changes in foreign currency exchange rates and interest rates. We believe our exposure to market risks is immaterial.

Exchange Rate Sensitivity

We are exposed to market risks associated with changes in foreign currency exchange rates because we generate a portion of our revenues and incur a portion of our expenses in currencies other than the U.S. dollar. As of March 31, 2024, we were exposed to changes in exchange rates between the U.S. dollar and twelve other currencies. We hedge material foreign

28

currency exchange rate exposures when feasible using forward contracts. These instruments are subject to fluctuations in foreign currency exchange rates and credit risk. Credit risk is managed through careful selection and ongoing evaluation of the financial institutions utilized as counterparties. Refer to Note 13, Derivatives, in the Notes to Interim Unaudited Condensed Consolidated Financial Statements for further discussion.

Interest Rate Sensitivity

As of March 31, 2024, there was no outstanding balance and $300.0 million of available borrowing capacity under our credit facility. To the extent we have outstanding borrowings under the credit facility, our interest expense will fluctuate as the interest rate for the line of credit floats based, at our option, on the prime rate plus a margin or the one-month SOFR rate plus a margin.

During the third quarter of 2020 and the fourth quarter of 2021, we issued the 2025 Notes and the 2026 Notes, respectively, which have a fixed interest rate of 1.250% and 0.125%, respectively. The fair value of the Notes may increase or decrease for various reasons, including fluctuations in the market price of our common stock, fluctuations in market interest rates and fluctuations in general economic conditions. Based upon the quoted market price as of March 31, 2024, the fair value of the 2025 Notes and 2026 Notes was approximately $28.3 million and $328.9 million, respectively.

We had unrestricted cash and cash equivalents totaling $118.0 million at March 31, 2024 and $128.7 million at December 31, 2023. The unrestricted cash and cash equivalents are primarily held for working capital purposes and acquisitions. We do not enter into investments for trading or speculative purposes.

Item 4. Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer of the Company, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, with the participation of the Company’s principal executive officer and principal financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on that evaluation, the Company’s principal executive and principal financial officers have determined that the Company’s disclosure controls and procedures were effective.

There were no significant changes in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the three months ended March 31, 2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1A. Risk Factors

In evaluating all forward-looking statements, you should specifically consider various risk factors that may cause actual results to vary from those contained in the forward-looking statements. Our risk factors are described in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 27, 2024 and available at www.sec.gov.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Securities

On January 16, 2024, the Company acquired all of the outstanding stock of SMEDIX. The consideration paid in this transaction included 68,441 unregistered shares of the Company’s common stock with an aggregate value of approximately $4.4 million based on the average closing sales price for the 15 consecutive trading days ending on the date immediately before the acquisition's closing date. We relied on Section 4(a)(2) of the Securities Act, as the basis for exemption from registration for each of these issuances. These shares were issued in privately negotiated transactions and not pursuant to a public solicitation.

29

Issuer Purchases of Equity Securities

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of shares of Company common stock through a stock repurchase program expiring December 31, 2024. The Company originally announced the repurchase program on March 27, 2008 and announced its expansion to its current authorization on October 27, 2022. The program could be suspended or discontinued at any time based on market, economic, or business conditions. The Company has no other stock repurchase programs outstanding, nor did any stock repurchase programs expire during the three months ended March 31, 2024.

From the program’s inception on August 11, 2008 through March 31, 2024, we have repurchased approximately $291.1 million (16.5 million shares) of our outstanding common stock. The Company did not repurchase any shares through the stock repurchase program during the three months ended March 31, 2024.

The Company intends for the stock repurchase program and the repurchases made pursuant to the program to reduce the dilutive effect of shares issued by the Company both to acquisition targets as part of its acquisition program and to key employees and executives as a principal component of the Company’s compensation practices. The Company’s use of shares for these purposes is critical because it allows for the Company to align the interests of our executives, acquisition targets and other employees with those of our stockholders and helps to retain key employees. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors.

The Company’s officers and directors are required to comply with the Company’s securities trading policy at all times, including during a repurchase program. The insider trading policy, among other things, prohibits trading in the Company’s securities when in possession of material non-public information and restricts the ability of directors and certain officers from transacting in the Company’s securities during specific blackout periods, subject to certain limited exceptions, including transactions pursuant to a Rule 10b5-1 trading arrangement that complies with the conditions of Exchange Act Rule 10b5-1.

Item 5. Other Information

Officer and Director Rule 10b5-1 Trading Arrangements

There were no Rule 10b5-1 trading arrangements adopted, materially modified, or terminated by our officers and directors during the first quarter of 2024.

Company Rule 10b5-1 Trading Arrangements

The Company did not adopt, materially modify, or terminate any Rule 10b5-1 trading arrangements during the first quarter of 2024.

Item 6. Exhibits

See Exhibits Index.

30

EXHIBITS INDEX

Exhibit Number	Description
3.1	Amended and Restated Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q filed July 27, 2023 and incorporated herein by reference
3.2	Second Amended and Restated Bylaws of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed on July 27, 2023 (File No. 001-15169) and incorporated herein by reference
4.1	Specimen Certificate for shares of Perficient, Inc. common stock, previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q (File No. 001-15169) filed May 7, 2009 and incorporated herein by reference
4.2	Indenture, dated August 14, 2020, between Perficient, Inc. and U.S. Bank National Association, as trustee, relating to the Company’s 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K (File No. 001-15169) filed August 18, 2020 and incorporated herein by reference
4.3	Form of 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed August 18, 2020 and incorporated herein by reference
4.4	Indenture, dated November 9, 2021, between Perficient, Inc. and U.S. Bank National Associate, as trustee, relating to the Company's 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
4.5	Form of 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
10.1†*	Amendment to Restricted Stock Award and Non-Competition Agreement between Perficient, Inc. and Jeffrey S. Davis, effective as of February 23, 2024
31.1*	Certification by the Chief Executive Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification by the Chief Financial Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Certification by the Chief Executive Officer and Chief Financial Officer of Perficient, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*	The following financial information from Perficient, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023, (ii) Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023, (iii) Unaudited Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2024 and 2023, (iv) Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three months ended March 31, 2024 and 2023, (v) Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023, and (vi) the Notes to Interim Unaudited Condensed Consolidated Financial Statements
104	Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101)
†	Identifies an Exhibit that consists of or includes a management contract or compensatory plan or arrangement.
*	Filed herewith.
**	Included but not to be considered “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

31

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		PERFICIENT, INC.
Date:	May 6, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer (Principal Executive Officer)

Date:	May 6, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer (Principal Financial Officer)

32

EX-10.1

Exhibit 10.1

AMENDMENT TO RESTRICTED STOCK AWARD AND NON-COMPETITION AGREEMENT

(EMPLOYEE GRANT)

THIS AMENDMENT TO RESTRICTED STOCK AWARD AND NON-COMPETITION AGREEMENT (this “Amendment”), dated as of February 23, 2024, is entered into between Perficient, Inc., a Delaware corporation (the “Corporation”), and Jeffrey S. Davis (“Employee”).

WITNESSETH:

WHEREAS, the Corporation and Employee have previously entered into certain Restricted Stock Award and Non-Competition Agreements, as described on Exhibit A (the “Award Agreements”), pursuant to which the Corporation granted certain awards (the “Awards”) of Restricted Shares of the Corporation’s authorized Common Stock, par value $0.001 per share, listed on Exhibit A, subject to the terms and conditions set forth in such Award Agreements and the Amended and Restated Perficient, Inc. 2012 Long Term Incentive Plan (the “Plan”) (capitalized terms used herein without definition shall have the meanings proscribed to them in each Award Agreement); and

WHEREAS, the Corporation and Employee desire to amend certain terms of each Award Agreement and the related Awards as set forth in this Amendment.

NOW, THEREFORE, in consideration of the matters referenced above, the parties agree as follows:

1.Amendments.

(a)A new Paragraph 2(s) is hereby added to each Award Agreement, which shall read in its entirety as follows:

(s) “Change in Control” means (1) the acquisition by one person, or more than one person acting as a group, of ownership of stock of the Corporation that, together with stock held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the stock of the Corporation; (2) the acquisition by one person, or more than one person acting as a group, of ownership of stock of the Corporation, that together with stock of the Corporation acquired during the 12-month period ending on the date of the most recent acquisition by such person or group, constitutes 30% or more of the total voting power of the stock of the Corporation; (3) a majority of the members of the Board of Directors is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors before the date of the appointment or election; or (4) one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or group) assets from the Corporation that have a total gross fair market value (determined without regard to any liabilities associated with such assets) equal to or more than 40% of the total gross fair market value of all of the assets of the Corporation immediately before such acquisition or acquisitions; provided , that persons will not be considered to be acting as a group solely because they purchase or own stock of the same corporation at the same time, or as a result of the same public offering, but persons will be considered to be acting as a group if they are owners of a corporation that entersinto a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Corporation; provided, further that this definition of Change in Control shall be interpreted in accordance with, and in a manner that will bring the definition into compliance with, the regulations under Section 409A of the Internal Revenue Code of 1986, as amended.

(b)The first sentence of Paragraph 6 of each Award Agreement is hereby deleted and replaced in its entirety by the following:

1

Exhibit 10.1

Subject to Paragraph 7(a), the restrictions on all of the Restricted Shares granted pursuant to this Agreement will expire and become transferable and non-forfeitable according to the schedule set forth in this Paragraph 6 so long as Employee has been performing Service continuously since the Date of Grant through the applicable vesting date; provided, that for the avoidance of doubt, Service for purposes of this Paragraph 6 shall include Employee’s performance of services for the Corporation as a member of the Board of Directors, whether or not Employee is also then an employee of the Corporation.

(c)The last sentence of Paragraph 6 of each Award Agreement is hereby deleted.

(d)Paragraph 7(a) of each Award Agreement is hereby deleted and replaced in its entirety by the following:

(a)Notwithstanding anything contained in Paragraph 6, the restrictions on all of the Restricted Shares granted pursuant to this Agreement will expire and become transferable and non-forfeitable on the occurrence of any of the following events: (1) a Change in Control; or (2) Employee no longer serving as a member of the Board of Directors as a result of (A) his death or disability, (B) his failure to be elected to the Board by the stockholders of the Company or (C) the Nominating, Governance and Sustainability Committee (or any successor thereto) failing to nominate him for election to the Board.

2.Miscellaneous.

(a)Except as expressly modified in this Amendment, the terms and conditions of each Award and each Award Agreement shall remain in full force and effect.

(b)This Amendment may be executed in two counterpart copies, each of which may be executed by one of the parties hereto, but all of which, when taken together, shall constitute a single agreement binding upon all of the parties hereto. This Amendment and all other aspects of the Employee’s employment shall be governed by and construed and interpreted in accordance with the internal laws of the State of Missouri without reference to conflicts of law principles, or any rule or decision that would defer to the substantive laws of another jurisdiction.

[THE REMAINDER OF THIS PAGE HAS BEEN LEFT INTENTIONALLY BLANK]

2

Exhibit 10.1

IN WITNESS WHEREOF, the Corporation has caused this Amendment to be executed by its duly authorized officer as of the date first above written.

PERFICIENT, INC.

By: /s/ Paul E. Martin        

Paul E. Martin

Chief Financial Officer

ACKNOWLEDGED AND AGREED:

/s/ Jeffrey S. Davis        

Jeffrey S. Davis

Date: February 23, 2024

3

Exhibit 10.1

Exhibit A

Award Agreements

Date of Award Agreement	No. of Shares of Restricted Stock Subject to Award	Unvested Awards at 3/1/2024
February 21, 2023	91,836	61,224
February 22, 2022	59,324	19,774

4

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Thomas J. Hogan, certify that:

    1. I have reviewed this quarterly report on Form 10-Q of Perficient, Inc.;

    2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

    3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

    4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

    (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

    (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

    (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

    (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

    5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

    (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

    (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 6, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Paul E. Martin, certify that:

    1. I have reviewed this quarterly report on Form 10-Q of Perficient, Inc.;

    2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

    3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

    4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

    (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

    (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

    (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

    (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

    5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

    (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

    (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 6, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

Pursuant to 18 U.S.C. Sec. 1350 and in connection with the accompanying report on Form 10-Q for the quarterly period ended March 31, 2024, that contains financial statements of Perficient, Inc. (the “Company”) filed for such period and that is being filed concurrently with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certify that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 6, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer (Principal Executive Officer)

Date:	May 6, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer (Principal Financial Officer)

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	Apr. 25, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-15169
Entity Registrant Name	PERFICIENT, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	74-2853258
Entity Address, Address Line One	555 Maryville University Drive
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Saint Louis
Entity Address, State or Province	MO
Entity Address, Postal Zip Code	63141
City Area Code	314
Local Phone Number	529-3600
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	PRFT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		35,156,319
Entity Central Index Key	0001085869
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 118,193	$ 128,886
Accounts receivable, net	171,838	178,998
Prepaid expenses	5,758	5,638
Other current assets	13,548	12,431
Total current assets	309,337	325,953
Property and equipment, net	10,375	11,996
Operating lease right-of-use assets	22,812	21,786
Goodwill	613,790	581,387
Intangible assets, net	75,430	71,118
Other non-current assets	53,936	52,364
Total assets	1,085,680	1,064,604
Current liabilities:
Accounts payable	13,919	18,688
Other current liabilities	60,104	59,784
Total current liabilities	74,023	78,472
Long-term debt, net	397,446	396,874
Operating lease liabilities	17,915	16,446
Other non-current liabilities	42,566	42,189
Total liabilities	531,950	533,981
Stockholders’ equity:
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of March 31, 2024 and December 31, 2023)	0	0
Common stock (par value $0.001 per share; 100,000,000 authorized; 53,833,315 shares issued and 34,455,848 shares outstanding as of March 31, 2024; 53,465,127 shares issued and 34,174,200 shares outstanding as of December 31, 2023)	54	53
Additional paid-in capital	448,855	432,160
Accumulated other comprehensive loss	(6,336)	(5,461)
Treasury stock, at cost (19,377,467 shares as of March 31, 2024; 19,290,927 shares as of December 31, 2023)	(377,594)	(373,325)
Retained earnings	488,751	477,196
Total stockholders’ equity	553,730	530,623
Total liabilities and stockholders’ equity	$ 1,085,680	$ 1,064,604

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	8,000,000	8,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	53,833,315	53,465,127
Common stock, shares outstanding	34,455,848	34,174,200
Treasury stock, shares	19,377,467	19,290,927

XML

Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Revenues	$ 215,304	$ 231,408
Cost of revenues (cost of services, exclusive of depreciation and amortization, shown separately below)
Cost of services	139,599	141,688
Stock compensation	2,507	2,524
Total cost of revenues	142,106	144,212
Selling, General and Administrative Expense [Abstract]
Selling, general and administrative	39,243	39,604
Stock compensation	9,923	4,316
Total selling, general and administrative	49,166	43,920
Depreciation	2,011	2,305
Amortization	4,886	5,817
Acquisition costs	1,393	79
Adjustment to fair value of contingent consideration	41	(2,026)
Income from operations	15,701	37,101
Net interest (income) expense	(767)	505
Net other (income) expense	(45)	75
Income before income taxes	16,513	36,521
Provision for income taxes	4,958	9,721
Net income	$ 11,555	$ 26,800
Basic net income per share (in dollars per share)	$ 0.34	$ 0.79
Diluted net income per share (in dollars per share)	$ 0.33	$ 0.75
Shares used in computing basic net income per share (in shares)	34,149	33,914
Shares used in computing diluted net income per share (in shares)	36,905	36,697

XML

Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 11,555	$ 26,800
Other comprehensive (loss) income:
Foreign currency translation adjustment, net of tax	(875)	1,772
Comprehensive income	$ 10,680	$ 28,572

XML

Unaudited Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at Dec. 31, 2022		$ 53	$ 403,866	$ (354,536)	$ (17,519)	$ 378,263
Balance (in shares) at Dec. 31, 2022	34,072,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		0	6,853
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			0
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	4,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			240
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	191,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	(106,000)
Foreign currency translation adjustment	$ 1,772				1,772
Purchases of treasury stock and buyback of shares for taxes				(7,449)
Escrow Shares Reqcquired				(164)
Net income	26,800					26,800
Balance at Mar. 31, 2023	$ 438,179	53	410,959	(362,149)	(15,747)	405,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	0
Stock Issued During Period, Shares, Escrow Shares	(2,000)
Balance (in shares) at Mar. 31, 2023	34,159,000
Balance at Dec. 31, 2023	$ 530,623	53	432,160	(373,325)	(5,461)	477,196
Balance (in shares) at Dec. 31, 2023	34,174,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		1	12,506
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			3,992
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	3,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			197
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	298,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	(87,000)
Foreign currency translation adjustment	$ (875)				(875)
Purchases of treasury stock and buyback of shares for taxes				(4,269)
Escrow Shares Reqcquired				0
Net income	11,555					11,555
Balance at Mar. 31, 2024	$ 553,730	$ 54	$ 448,855	$ (377,594)	$ (6,336)	$ 488,751
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	68,000
Stock Issued During Period, Shares, Escrow Shares	0
Balance (in shares) at Mar. 31, 2024	34,455,848

XML

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net income	$ 11,555	$ 26,800
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	2,011	2,305
Amortization	4,886	5,817
Deferred income taxes	(796)	(1,885)
Non-cash stock compensation and retirement savings plan contributions	12,222	6,674
Amortization of debt issuance costs	631	608
Adjustment to fair value of contingent consideration for purchase of businesses	41	(2,026)
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	10,928	18,784
Other assets	(1,360)	5,705
Accounts payable	(4,824)	(9,909)
Other liabilities	(3,323)	(11,542)
Net cash provided by operating activities	31,971	41,331
Investing Activities
Purchase of property and equipment	(319)	(1,015)
Capitalization of internally developed software costs	(341)	(328)
Purchase of businesses, net of cash acquired	(33,157)	28
Net cash used in investing activities	(33,817)	(1,315)
Financing Activities
Payment for credit facility financing fees	0	(683)
Payment of contingent consideration for purchase of business	(4,516)	(21,530)
Proceeds from the sale of stock through the Employee Stock Purchase Plan	197	240
Purchases of treasury stock	0	(2,395)
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(4,269)	(5,054)
Net cash used in financing activities	(8,588)	(29,422)
Effect of exchange rate on cash, cash equivalents and restricted cash	(259)	271
Change in cash, cash equivalents and restricted cash	(10,693)	10,865
Cash, cash equivalents and restricted cash at beginning of period	128,886	30,130
Cash, cash equivalents and restricted cash at end of period	118,193	40,995
Supplemental Disclosures:
Cash paid for income taxes	2,770	1,553
Cash paid for interest	278	136
Stock issued for purchase of businesses (stock reacquired for escrow claim)	$ 3,809	$ (164)

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying interim unaudited condensed consolidated financial statements of Perficient, Inc. and its subsidiaries (collectively, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Accordingly, certain note disclosures have been condensed or omitted. In the opinion of management, the interim unaudited condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Certain reclassifications were made to prior year amounts to conform to the 2024 presentation.

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements.

There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2023 that have had a material impact on the Company’s condensed consolidated financial statements and related notes.

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2024

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) Improvements To Reportable Segment Disclosures, which requires additional disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The Company will adopt this ASU retrospectively for the annual period beginning on January 1, 2024 and for interim periods beginning on January 1, 2025.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements To Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company expects to adopt this ASU prospectively for the annual period beginning on January 1, 2025.

XML

Revenue

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

The Company’s revenues consist of services and software and hardware sales. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of services or goods are transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services or goods.

Services Revenues

Services revenues are primarily comprised of professional services that include developing, implementing, automating and extending business processes, technology infrastructure, and software applications. The Company’s professional services span multiple industries, platforms and solutions; however, the Company has remained relatively diversified and does not believe that it has significant revenue concentration within any single industry, platform or solution.

Professional services revenues are recognized over time as services are rendered. Most projects are performed on a time and materials basis, while a portion of revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material contracts, revenues are generally recognized and invoiced by multiplying the number of hours expended in the performance of the contract by the hourly rates. For fixed fee contracts, revenues are generally recognized and invoiced by multiplying the fixed rate per time period established in the contract by the number of time periods elapsed. For fixed fee percent complete contracts, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours, and the client is invoiced according to the agreed-upon schedule detailing the amount and timing of payments in the contract.

Clients are typically billed monthly for services provided during that month but can be billed on a more or less frequent basis as determined by the contract. If the time is worked and approved at the end of a fiscal period and the invoice has not yet been sent to the client, the amount is recorded as revenue once the Company verifies all other revenue recognition criteria have been met, and the amount is classified as a receivable as the right to consideration is unconditional at that point. Amounts invoiced in excess of revenues recognized are contract liabilities, which are classified as deferred revenues in the Unaudited Condensed Consolidated Balance Sheet. The term between invoicing and payment due date is not significant. Contracts for professional services provide for a general right, to the client or the Company, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract. Certain contracts may include volume discounts or holdbacks, which are accounted for as variable consideration, but are not typically significant. The Company estimates variable consideration based on historical experience and forecasted sales and includes the variable consideration in the transaction price.

Other services revenues are comprised of hosting fees, partner referral fees, maintenance agreements, training and internally developed software-as-a-service (“SaaS”) sales. Revenues from hosting fees, maintenance agreements, training and internally developed SaaS sales are generally recognized over time using a time-based measure of progress as services are rendered. Partner referral fees are recorded at a point in time upon meeting specified requirements to earn the respective fee.

On many professional service projects, the Company is also reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract and are invoiced as the expenses are incurred. The Company structures its professional services arrangements to recover the cost of reimbursable expenses without a markup.

Software and Hardware Revenues

Software and hardware revenues are comprised of third-party software and hardware resales, in which the Company is considered the agent, and sales of internally developed software, in which the Company is considered the principal. Third-party software and hardware revenues are recognized and invoiced when the Company fulfills its obligation to arrange the sale, which occurs when the purchase order with the vendor is executed and the customer has access to the software or the hardware has been shipped to the customer. Internally developed software revenues are recognized and invoiced when control is transferred to the customer, which occurs when the software has been made available to the customer and the license term has commenced. Revenues from third-party software and hardware sales are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. There are no significant cancellation or termination-type provisions for the Company’s software and hardware sales, and the term between invoicing and payment due date is not significant.

Revenues are presented net of taxes assessed by governmental authorities. Sales taxes are generally collected and subsequently remitted on all software and hardware sales and certain services transactions as appropriate.

Arrangements with Multiple Performance Obligations

Arrangements with clients may contain multiple promises such as delivery of software, hardware, professional services or post-contract support services. These promises are accounted for as separate performance obligations if they are distinct. For arrangements with clients that contain multiple performance obligations, the transaction price is allocated to the separate performance obligations based on estimated relative standalone selling price, which is estimated by the expected cost plus a margin approach, taking into consideration market conditions and competitive factors. Because contracts that contain multiple performance obligations are typically short term due to the contract cancellation provisions, the allocation of the transaction price to the separate performance obligations is not considered a significant estimate.

Contract Costs

In accordance with the terms of the Company’s sales commission plan, commissions are not earned until the related revenue is recognized. Therefore, sales commissions are expensed as they are earned. Certain sales incentives are accrued based on achievement of specified bookings goals. For these incentives, the Company applies the practical expedient that allows the Company to expense the incentives as incurred because the amortization period would have been one year or less.

Deferred Revenue

The Company’s deferred revenue balance as of March 31, 2024 and December 31, 2023 was $3.3 million and $5.5 million, respectively. Substantially all of the December 31, 2023 deferred revenue balance was recognized in revenue during the three months ended March 31, 2024.

Transaction Price Allocated to Remaining Performance Obligations

Due to the ability of the client or the Company to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required), the majority of the Company’s contracts have a term of less than one year. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original maturity date of one year or less or time and materials contracts for which the Company has the right to invoice for services performed. Revenue related to unsatisfied performance obligations for remaining contracts as of March 31, 2024 was immaterial.

Disaggregation of Revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):

	Three Months Ended March 31,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	154.2	$	—	$	154.2	$	175.5	$	—	$	175.5
Fixed fee percent complete contracts	14.9		—		14.9		14.8		—		14.8
Fixed fee contracts	40.7		—		40.7		36.3		—		36.3
Reimbursable expenses	3.6		—		3.6		2.5		—		2.5
Total professional services fees	213.4		—		213.4		229.1		—		229.1
Other services revenue*	1.2		0.3		1.5		1.4		0.3		1.7
Total services	214.6		0.3		214.9		230.5		0.3		230.8
Software and hardware	—		0.4		0.4		—		0.6		0.6
Total revenues	$	214.6	$	0.7	$	215.3	$	230.5	$	0.9	$	231.4

*Other services revenue primarily consists of hosting fees, maintenance, training, internally developed SaaS revenue and partner referral fees.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):

	Three Months Ended March 31,
	2024		2023
United States	$	205.6	$	223.5
Other countries	9.7		7.9
Total revenues	$	215.3	$	231.4

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Stock-based compensation is accounted for in accordance with ASC Topic 718, Compensation – Stock Compensation. Under this guidance, the Company recognizes share-based compensation ratably using the straight-line attribution method over the requisite service period, which is generally three years. The fair value of restricted stock awards is based on the value of the Company’s common stock on the date of the grant.

The Company’s Third Amended and Restated 2012 Long Term Incentive Plan (as amended, the “Incentive Plan”) allows for the granting of various types of stock awards, not to exceed a total of 8.5 million shares, to eligible individuals. The Compensation Committee of the Board of Directors administers the Incentive Plan and determines the terms of all stock awards made under the Incentive Plan. As of March 31, 2024, there were 1.8 million shares of common stock available for issuance under the Incentive Plan.

Stock-based compensation cost recognized for the three months ended March 31, 2024 was $12.4 million, which included $1.0 million of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $3.7 million for the three months ended March 31, 2024. Stock-based compensation cost recognized for the three months ended March 31, 2023 was $6.8 million, which included $1.1 million of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $1.8 million for the three months ended March 31, 2023.

On February 23, 2024, Jeffrey S. Davis resigned his employee position as Executive Chairman of the Company, effective as of March 1, 2024. Mr. Davis is continuing as the non-executive Chairman of the Board of Directors. In connection with Mr. Davis’s resignation, the Board of Directors approved an amendment to certain existing restricted stock award agreements. Due to the resignation of Mr. Davis as Executive Chairman of the Company and the related restricted stock award amendment, the incremental share based compensation expense recorded during the three months ended March 31, 2024 was approximately $5.6 million.

Restricted Stock Awards (“RSAs”)

Restricted stock activity for the three months ended March 31, 2024 was as follows (shares in thousands):

 

	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.04
Awards vested	(194)	73.93
Awards forfeited	(17)	68.42
Restricted stock awards outstanding at March 31, 2024	698	$	69.50

As of March 31, 2024, there was $37.0 million of total unrecognized compensation cost related to non-vested RSAs with a weighted-average remaining life of two years.    

Performance Stock Awards (“PSAs”)

In connection with the announcement of Thomas J. Hogan’s promotion to Chief Executive Officer, the Company granted a PSA of 10,842 shares to Mr. Hogan on July 25, 2023 under the Incentive Plan with terms determined at the discretion of the Compensation Committee of the Board of Directors. The actual number of shares subject to the PSA that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Nasdaq Composite Index over a three-year period. The grant date fair value of $80.90 per share was based on a Monte Carlo simulation model as of the date of the award. PSA related stock-based compensation cost recognized for the three months ended March 31, 2024 was $0.1 million. As of March 31, 2024, there was $0.7 million of total unrecognized compensation cost related to unvested PSAs, expected to be recognized over a period of three years.

XML

Net Income per Share

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Net Income per Share

Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):

	Three Months Ended
	March 31,
	2024		2023
Net income, basic	$	11,555	$	26,800
Add back interest expense on convertible notes, net of tax	534		560
Net income, diluted	$	12,089	$	27,360
Basic:
Weighted-average shares of common stock outstanding	34,149		33,914
Shares used in computing basic net income per share	34,149		33,914
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	177		154
Shares issuable for acquisition consideration (1)	149		199
Shares issuable for conversion of convertible senior notes	2,430		2,430
Shares used in computing diluted net income per share	36,905		36,697
Basic net income per share	$	0.34	$	0.79
Diluted net income per share	$	0.33	$	0.75

(1)For the three months ended March 31, 2024, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Purchase Agreement with Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (collectively, “Talos”); (iii) the Stock Purchase Agreement with the shareholders of Izmul S.A. (“Overactive”); (iv) the Purchase Agreement with the shareholders of Ameex Technologies Corporation (“Ameex”); and (v) the Purchase Agreement with the shareholders of SMEDIX, Inc. (“SMEDIX”), as part of the consideration. For the three months ended March 31, 2023, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon; (ii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); (iii) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”); (iv) the Purchase Agreement with Talos; (v) the Stock Purchase Agreement with the shareholders of Overactive; (vi) the Stock Purchase Agreement with the shareholders of Inflection Point Systems, Inc.; and (vii) the Purchase Agreement with the shareholders of Ameex, as part of the consideration.

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):

	Three Months Ended
	March 31,
	2024	2023
Restricted stock and performance stock awards subject to vesting	109	276
Warrants related to the issuance of convertible senior notes	2,431	2,431
Total anti-dilutive securities	2,540	2,707

See Note 11, Long-term Debt for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of Company common stock through a stock repurchase program expiring December 31, 2024. The program could be suspended or discontinued at any time,

based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately $291.1 million (16.5 million shares) of outstanding common stock through March 31, 2024.

XML

Balance Sheet Components

3 Months Ended

Mar. 31, 2024

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

Balance Sheet Components

	March 31, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	97.6	$	119.9
Unbilled revenues, net	74.2		59.1
Total	$	171.8	$	179.0

Other current assets:
Miscellaneous receivables	$	3.5	$	3.1
Contractual commitment asset	3.4		3.0
Income tax receivable	3.2		2.7
Other current assets	3.4		3.6
Total	$	13.5	$	12.4

Property and equipment:
Computer hardware (useful life of 3 years)	$	25.5	$	26.7
Software (useful life of 1 to 7 years)	9.1		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.8		7.8
Less: Accumulated depreciation	(36.3)		(36.2)
Total	$	10.4	$	12.0

Other non-current assets:
Non-current unbilled revenue	$	1.3	$	2.2
Company owned life insurance asset	13.9		12.6
Long term deposits	1.9		1.8
Credit facility deferred finance fees, net	1.0		1.0
Other non-current assets	13.6		13.2
Deferred income taxes	22.2		21.6
Total	$	53.9	$	52.4

Other current liabilities:
Estimated fair value of contingent consideration liability (Note 9)	$	6.4	$	4.5
Accrued variable compensation	13.1		15.9
Current operating lease liabilities	6.4		7.0
Payroll related costs	11.2		11.1
Deferred revenues	3.3		5.5
Income tax payable	4.7		1.5
Other current liabilities	5.8		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	1.8		1.3
Accrued IT expenses	5.1		5.0
Total	$	60.1	$	59.8

	March 31, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	5.4	$	5.9
Reserve for uncertain tax positions	18.4		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	4.6		5.0
Non-current software accrual	1.7		2.6
Total	$	42.6	$	42.2

XML

Allowance for Credit Losses

3 Months Ended

Mar. 31, 2024

Credit Loss [Abstract]

Allowance for Credit Losses

Allowance for Credit Losses

In accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company evaluates its allowance based on expected losses rather than incurred losses, which is known as the current expected credit loss model. The allowance is determined using the loss rate approach and is measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts.

Activity in the allowance for credit losses is summarized as follows (in millions):

	Three Months Ended March 31,
	2024		2023
Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	(0.1)		—
Other (1)	(0.5)		(1.2)
Balance at March 31	$	1.9	$	4.6

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

XML

Business Combinations

3 Months Ended

Mar. 31, 2024

Business Combinations [Abstract]

Business Combinations

Business Combinations

2024 Acquisition

On January 16, 2024, the Company acquired all of the outstanding capital stock of SMEDIX. SEMDIX is a healthcare software engineering firm headquartered in San Diego, California, with offshore operations located in Cluj-Napoca, Romania. The acquisition of SMEDIX continued to strengthen our healthcare industry digital capabilities, enhance our global delivery capacity, and expand further within Eastern Europe. SMEDIX added more than 175 professionals and strategic client relationships focused in the biomedical and healthcare industry. The Company’s total allocable purchase price consideration was $43.6 million, net of cash acquired. The Company incurred approximately $1.7 million in transaction costs, which were expensed when incurred. The amount of goodwill deductible for tax purposes is $33.6 million.

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):

	SMEDIX
Cash, net of cash acquired	$	33.2
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.6

(1)Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the closing date of the acquisition.

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of March 31, 2024, the fair value of the contingent consideration was $6.4 million.

The Company has estimated the preliminary allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

	SMEDIX
Acquired tangible assets	$	4.9
Identified intangible assets	8.9
Liabilities assumed	(3.1)
Goodwill	32.9
Total allocable purchase price consideration	$	43.6

The following table presents details of the intangible assets acquired during the three months ended March 31, 2024.

	Weighted Average Useful Life	Estimated Useful Life	SMEDIX
Customer relationships	6 years	6 years	$	7.0
Customer backlog	1 year	1 year	1.7
Non-compete agreements	5 years	5 years	0.1
Trade name	1 year	1 year	0.1
Total acquired intangible assets			$	8.9

The above purchase price accounting estimates for SMEDIX are pending finalization of certain acquired tangible and intangible assets, contingent consideration valuation, and a net working capital settlement that is subject to final adjustment as the Company evaluates information during the measurement period.

Pro-forma Results of Operations

Pro-forma results of operations have not been presented for SMEDIX because the effect of the acquisition on the Company's condensed consolidated financial statements was not material.

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill represents the excess purchase price over the fair value of net assets acquired, or net liabilities assumed, in a business combination. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, the Company performs an annual impairment review in the fourth quarter and more frequently if events or changes in circumstances indicate that goodwill might be impaired. There was no indication that goodwill became impaired for the three months ended March 31, 2024.

Other intangible assets include customer relationships, non-compete arrangements, trade names, customer backlog, and developed software, which are being amortized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives range from less than one year to ten years. Amortization of customer relationships, non-compete arrangements, trade names, customer backlog, and developed software is considered an operating expense and is included in “Amortization” in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in a lack of recoverability or revised useful life. There was no indication that other intangible assets became impaired for the three months ended March 31, 2024.

Goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 are as follows (in millions):

 

Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.9
Effect of foreign currency translation adjustments	(0.5)
Balance at March 31, 2024	$	613.8

Intangible Assets with Definite Lives

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):

	March 31, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	122.9	$	(51.1)	$	71.8	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.6)		0.6		1.1		(0.6)		0.5
Customer backlog	1.7		(0.4)		1.3		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	8.8		(7.2)		1.6		8.5		(6.7)		1.8
Total	$	135.5	$	(60.1)	$	75.4	$	126.5	$	(55.4)	$	71.1

The estimated useful lives of identifiable intangible assets are as follows:

 

Customer relationships	5 - 10 years
Non-compete agreements	4 - 5 years
Customer backlog	1 year
Trade name	1 year
Developed software	1 - 7 years

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):

2024 remaining	$	13.9
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

XML

Long-term Debt

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Long-term Debt

Long-term Debt

Revolving Credit Facility

On March 29, 2023, the Company amended and restated its existing credit agreement by entering into a Second Amended and Restated Credit Agreement (the “2023 Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding

amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of March 31, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred finance fees during the three months ended March 31, 2023.

The 2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of March 31, 2024, there were no outstanding letters of credit. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the 2023 Credit Agreement bear interest at the Company’s option of the prime rate (8.50% on March 31, 2024) plus a margin ranging from 0.00% to 1.00% or one month Secured Overnight Financing Rate (“SOFR”) (5.34% on March 31, 2024) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of March 31, 2024, the Company had $300.0 million of unused borrowing capacity.

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At March 31, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

On November 9, 2021, the Company issued $380.0 million aggregate principal amount of 0.125% Convertible Senior Notes Due 2026 (the “2026 Notes”) in a private placement to qualified institutional buyers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The 2026 Notes bear interest at a rate of 0.125% per year. Interest is payable in cash on May 15 and November 15 of each year, with the first payment made on May 15, 2022. The 2026 Notes mature on November 15, 2026 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 5.2100 shares of the Company’s common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $191.94 per share of common stock. After consideration of the 2026 Notes Hedges and 2026 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $295.29 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2026 Notes (the “2026 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2026 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2026 Notes in cash upon conversion.

Convertible Senior Notes due 2025

On August 14, 2020, the Company issued $230.0 million aggregate principal amount of 1.250% Convertible Senior Notes Due 2025 (the “2025 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The 2025 Notes bear interest at a rate of 1.250% per year. Interest is payable in cash on February 1 and August 1 of each year. The 2025 Notes mature on August 1, 2025 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 19.3538 shares of the Company’s common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $51.67 per share of common stock. After consideration of the 2025 Notes Hedges and 2025 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $81.05 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2025 Notes (the “2025 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2025 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2025 Notes in cash upon conversion.

Other Terms of the Notes

The 2025 Notes and 2026 Notes may be converted at the holder’s option prior to the close of business on the business day immediately preceding August 1, 2025 for the 2025 Notes and November 15, 2026 for the 2026 Notes, but only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 for the 2025 Notes and December 31, 2021 for the 2026 Notes, if the last reported sale price per share of the Company’s common stock exceeds 130% of the applicable conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

•during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the applicable conversion rate on such trading day;

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

•at any time from, and including, February 3, 2025 for 2025 Notes and May 15, 2026 for 2026 Notes, until the close of business on the second scheduled trading day immediately before the maturity date for the 2025 Notes and 2026 Notes.

The Company may not redeem the 2025 Notes and 2026 Notes at its option before maturity. If a “fundamental change” (as defined in the 2025 Indenture and 2026 Indenture) occurs, then, except as described in the 2025 Indenture and 2026 Indenture, noteholders may require the Company to repurchase their 2025 Notes and 2026 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes and 2026 Notes to be repurchased, plus accrued and unpaid interest, if any.

As of March 31, 2024, none of the conditions permitting holders to convert their 2025 Notes and 2026 Notes had been satisfied and no shares of the Company’s common stock had been issued in connection with any conversions of the 2025 Notes and 2026 Notes during the three months ended March 31, 2024. Based on the closing price of the Company's common stock of $56.29 per share on March 31, 2024, the conversion value of the 2026 Notes was less than the principal amount of the 2026 Notes outstanding on a per note basis, and the conversion value of the 2025 Notes was greater than the principal amount of the 2025 Notes outstanding on a per note basis.

The 2025 Notes and 2026 Notes consisted of the following (in millions):

	March 31, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.6)		(0.2)
Net carrying amount	$	374.4	$	23.1

	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three months ended March 31, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	0.6		0.6
Total interest expense recognized	$	0.7	$	0.7

2025 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	—		—
Total interest expense recognized	$	0.1	$	0.1

Convertible Notes Hedges

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company entered into privately negotiated convertible note hedge transactions (the “2026 Notes Hedges” and the “2025 Notes Hedges”), and together, the “Notes Hedges”) with certain of the initial purchasers or their respective affiliates and/or other financial institutions (the “Option Counterparties”). As of March 31, 2024, the 2026 Notes Hedges provide the Company with the option to acquire, on a net settlement basis, approximately 2.0 million shares of common stock at a strike price of $191.94, which is equal to the number of shares of common stock that notionally underlie the 2026 Notes and correspond to the conversion price of the 2026 Notes. As of March 31, 2024, the 2025 Notes Hedges provided the Company with the option to acquire, on a net settlement basis, approximately 0.5 million shares of common stock at a strike price of $51.67, which is equal to the number of shares of common stock that notionally underlie the 2025 Notes and correspond to the conversion price of the 2025 Notes. If the Company elects cash settlement and exercises the Notes Hedges, the aggregate amount of cash received from the Option Counterparties will cover the aggregate amount of cash that the Company would be required to pay to the holders of the Notes, less the principal amount thereof. The Notes Hedges do not meet the criteria for separate accounting as a derivative as they are indexed to the Company’s stock and are accounted for as freestanding financial instruments.

Convertible Notes Warrants

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company also sold net-share-settled warrants (the “2026 Notes Warrants” and the “2025 Notes Warrants,” respectively, and together, the “Notes Warrants”) in privately negotiated transactions with the Option Counterparties. The strike price of the 2026 Notes Warrants and 2025 Notes Warrants was approximately $295.29 and $81.05 per share, respectively, and is subject to certain adjustments under the terms of their respective Notes Warrants. As a result of the 2026 Notes Warrants and 2025 Notes Warrants and related transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price for any fiscal quarter is over $295.29 for the 2026 Notes Warrants and $81.05 for the 2025 Notes Warrants. The 2026 Notes Warrants and the 2025 Notes Warrants expire over a period of 80 trading days commencing on February 15, 2027 and over a period of 100 trading days commencing on November 1, 2025, respectively, and may be settled in net shares of common stock or net cash at the Company’s election. As of March 31, 2024, 2.0 million warrant shares and 0.5 million warrant shares were outstanding for the 2026 Notes Warrants and 2025 Notes Warrants, respectively.

XML

Income Taxes

3 Months Ended

Mar. 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company's effective tax rate was 30.0% for the three months ended March 31, 2024, which was higher than the U.S. statutory rate of 21.0% primarily due to state taxes, share-based compensation and Section 162(m) compensation limitations.

The Company’s effective tax rate was 26.6% for the three months ended March 31, 2023, which was higher than the U.S. statutory rate of 21.0% primarily due to state taxes and foreign operations.

XML

Derivatives

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

Derivatives

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company’s derivative financial instruments consist of non-deliverable and deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net loss of $0.2 million during the three months ended March 31, 2024. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net gain of $0.4 million during the three months ended March 31, 2023. Gains and losses on these contracts are recorded in net other expense (income) and net interest expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	28.2	$	26.2
Total derivatives not designated as hedges	$	28.2	$	26.2

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

The carrying value of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments.

All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of March 31, 2024 and December 31, 2023, $54.5 million and $45.3 million, respectively of the Company’s cash, cash equivalents and restricted cash balance related to Level 1 investments.

The Company has a deferred compensation plan, which is funded through Company owned life insurance (“COLI”) policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was $13.9 million and $12.6 million as of March 31, 2024 and December 31, 2023, respectively.

The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of March 31, 2024 and December 31, 2023 were immaterial.

The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 7, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of March 31, 2024 and December 31, 2023.

The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease.

The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of March 31, 2024 and December 31, 2023 was $328.9 million and $316.1 million, respectively. The approximate fair value of the 2025 Notes as of March 31, 2024 and December 31, 2023 was $28.3 million and $32.4 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

XML

Leases

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Leases

Leases

The Company leases office space under various operating lease agreements, which have remaining lease terms of less than one year to seven years. Operating leases are included in operating lease right-of-use assets, other current liabilities, and operating lease liabilities on the consolidated balance sheet. Operating lease expense for the three months ended March 31, 2024 and 2023 were $3.0 million and $3.3 million, respectively.

Supplemental balance sheet information related to leases was as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.4	$	7.0
Operating lease liabilities	17.9		16.4
Total	$	24.3	$	23.4

Future minimum lease payments as of March 31, 2024 were as follows (in millions):

	March 31, 2024 (unaudited)
2024 remaining	$	5.4
2025	6.9
2026	4.8
2027	4.5
2028	3.4
Thereafter	2.0
Total future lease payments	27.0
Less implied interest	(2.7)
Total	$	24.3

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

Subsequent Event

On May 5, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Plano HoldCo, Inc., a Delaware corporation (“Parent”), and Plano BidCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Parent and Merger Sub are affiliates of EQT Asia. Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the “Merger” and, collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). Under the terms of the Merger Agreement, the Company’s stockholders will receive $76.00 in cash per share of Company common stock outstanding as of the closing of the Merger.

Consummation of the Merger is subject to various conditions, including, among others, customary conditions relating to the adoption of the Merger Agreement by the holders of a majority of the Company’s outstanding common stock, the expiration or termination of any applicable waiting periods under the Hart-Scott-Rodino Act, conclusion of any review or investigation of the Transactions by the Committee on Foreign Investment in the United States, the receipt of certain foreign regulatory approvals and other customary conditions for a transaction of this type, such as the absence of any legal restraint prohibiting the consummation of the Transactions and the absence of any Company Material Adverse Effect (as defined in the Merger Agreement). Consummation of the Merger is not subject to any financing condition, and is expected to occur by the end of 2024.

The Company expects to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger Agreement. If the Merger Agreement is terminated under specified circumstances, Parent may be required to pay a termination fee of $162.6 million to the Company.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements.

There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2023 that have had a material impact on the Company’s condensed consolidated financial statements and related notes.

Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) Improvements To Reportable Segment Disclosures, which requires additional disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The Company will adopt this ASU retrospectively for the annual period beginning on January 1, 2024 and for interim periods beginning on January 1, 2025.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements To Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company expects to adopt this ASU prospectively for the annual period beginning on January 1, 2025.

Revenue from Contract with Customer

The Company’s revenues consist of services and software and hardware sales. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of services or goods are transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services or goods.

Services Revenues

Services revenues are primarily comprised of professional services that include developing, implementing, automating and extending business processes, technology infrastructure, and software applications. The Company’s professional services span multiple industries, platforms and solutions; however, the Company has remained relatively diversified and does not believe that it has significant revenue concentration within any single industry, platform or solution.

Professional services revenues are recognized over time as services are rendered. Most projects are performed on a time and materials basis, while a portion of revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material contracts, revenues are generally recognized and invoiced by multiplying the number of hours expended in the performance of the contract by the hourly rates. For fixed fee contracts, revenues are generally recognized and invoiced by multiplying the fixed rate per time period established in the contract by the number of time periods elapsed. For fixed fee percent complete contracts, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours, and the client is invoiced according to the agreed-upon schedule detailing the amount and timing of payments in the contract.

Clients are typically billed monthly for services provided during that month but can be billed on a more or less frequent basis as determined by the contract. If the time is worked and approved at the end of a fiscal period and the invoice has not yet been sent to the client, the amount is recorded as revenue once the Company verifies all other revenue recognition criteria have been met, and the amount is classified as a receivable as the right to consideration is unconditional at that point. Amounts invoiced in excess of revenues recognized are contract liabilities, which are classified as deferred revenues in the Unaudited Condensed Consolidated Balance Sheet. The term between invoicing and payment due date is not significant. Contracts for professional services provide for a general right, to the client or the Company, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract. Certain contracts may include volume discounts or holdbacks, which are accounted for as variable consideration, but are not typically significant. The Company estimates variable consideration based on historical experience and forecasted sales and includes the variable consideration in the transaction price.

Other services revenues are comprised of hosting fees, partner referral fees, maintenance agreements, training and internally developed software-as-a-service (“SaaS”) sales. Revenues from hosting fees, maintenance agreements, training and internally developed SaaS sales are generally recognized over time using a time-based measure of progress as services are rendered. Partner referral fees are recorded at a point in time upon meeting specified requirements to earn the respective fee.

On many professional service projects, the Company is also reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract and are invoiced as the expenses are incurred. The Company structures its professional services arrangements to recover the cost of reimbursable expenses without a markup.

Software and Hardware Revenues

Software and hardware revenues are comprised of third-party software and hardware resales, in which the Company is considered the agent, and sales of internally developed software, in which the Company is considered the principal. Third-party software and hardware revenues are recognized and invoiced when the Company fulfills its obligation to arrange the sale, which occurs when the purchase order with the vendor is executed and the customer has access to the software or the hardware has been shipped to the customer. Internally developed software revenues are recognized and invoiced when control is transferred to the customer, which occurs when the software has been made available to the customer and the license term has commenced. Revenues from third-party software and hardware sales are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. There are no significant cancellation or termination-type provisions for the Company’s software and hardware sales, and the term between invoicing and payment due date is not significant.

Revenues are presented net of taxes assessed by governmental authorities. Sales taxes are generally collected and subsequently remitted on all software and hardware sales and certain services transactions as appropriate.

Arrangements with Multiple Performance Obligations

Arrangements with clients may contain multiple promises such as delivery of software, hardware, professional services or post-contract support services. These promises are accounted for as separate performance obligations if they are distinct. For arrangements with clients that contain multiple performance obligations, the transaction price is allocated to the separate performance obligations based on estimated relative standalone selling price, which is estimated by the expected cost plus a margin approach, taking into consideration market conditions and competitive factors. Because contracts that contain multiple performance obligations are typically short term due to the contract cancellation provisions, the allocation of the transaction price to the separate performance obligations is not considered a significant estimate.

Contract Costs

In accordance with the terms of the Company’s sales commission plan, commissions are not earned until the related revenue is recognized. Therefore, sales commissions are expensed as they are earned. Certain sales incentives are accrued based on achievement of specified bookings goals. For these incentives, the Company applies the practical expedient that allows the Company to expense the incentives as incurred because the amortization period would have been one year or less.

Stock-Based Compensation

Stock-based compensation is accounted for in accordance with ASC Topic 718, Compensation – Stock Compensation. Under this guidance, the Company recognizes share-based compensation ratably using the straight-line attribution method over the requisite service period, which is generally three years. The fair value of restricted stock awards is based on the value of the Company’s common stock on the date of the grant.

Allowance for Credit Losses

In accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company evaluates its allowance based on expected losses rather than incurred losses, which is known as the current expected credit loss model. The allowance is determined using the loss rate approach and is measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts.

Goodwill and Intangible Assets

Goodwill represents the excess purchase price over the fair value of net assets acquired, or net liabilities assumed, in a business combination. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, the Company performs an annual impairment review in the fourth quarter and more frequently if events or changes in circumstances indicate that goodwill might be impaired. There was no indication that goodwill became impaired for the three months ended March 31, 2024.

Other intangible assets include customer relationships, non-compete arrangements, trade names, customer backlog, and developed software, which are being amortized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives range from less than one year to ten years. Amortization of customer relationships, non-compete arrangements, trade names, customer backlog, and developed software is considered an operating expense and is included in “Amortization” in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in a lack of recoverability or revised useful life. There was no indication that other intangible assets became impaired for the three months ended March 31, 2024.

Long-term Debt

Long-term Debt

Revolving Credit Facility

On March 29, 2023, the Company amended and restated its existing credit agreement by entering into a Second Amended and Restated Credit Agreement (the “2023 Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding

amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of March 31, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred finance fees during the three months ended March 31, 2023.

The 2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of March 31, 2024, there were no outstanding letters of credit. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the 2023 Credit Agreement bear interest at the Company’s option of the prime rate (8.50% on March 31, 2024) plus a margin ranging from 0.00% to 1.00% or one month Secured Overnight Financing Rate (“SOFR”) (5.34% on March 31, 2024) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of March 31, 2024, the Company had $300.0 million of unused borrowing capacity.

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At March 31, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

On November 9, 2021, the Company issued $380.0 million aggregate principal amount of 0.125% Convertible Senior Notes Due 2026 (the “2026 Notes”) in a private placement to qualified institutional buyers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The 2026 Notes bear interest at a rate of 0.125% per year. Interest is payable in cash on May 15 and November 15 of each year, with the first payment made on May 15, 2022. The 2026 Notes mature on November 15, 2026 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 5.2100 shares of the Company’s common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $191.94 per share of common stock. After consideration of the 2026 Notes Hedges and 2026 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $295.29 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2026 Notes (the “2026 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2026 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2026 Notes in cash upon conversion.

Convertible Senior Notes due 2025

On August 14, 2020, the Company issued $230.0 million aggregate principal amount of 1.250% Convertible Senior Notes Due 2025 (the “2025 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The 2025 Notes bear interest at a rate of 1.250% per year. Interest is payable in cash on February 1 and August 1 of each year. The 2025 Notes mature on August 1, 2025 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 19.3538 shares of the Company’s common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $51.67 per share of common stock. After consideration of the 2025 Notes Hedges and 2025 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $81.05 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2025 Notes (the “2025 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2025 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2025 Notes in cash upon conversion.

Other Terms of the Notes

The 2025 Notes and 2026 Notes may be converted at the holder’s option prior to the close of business on the business day immediately preceding August 1, 2025 for the 2025 Notes and November 15, 2026 for the 2026 Notes, but only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 for the 2025 Notes and December 31, 2021 for the 2026 Notes, if the last reported sale price per share of the Company’s common stock exceeds 130% of the applicable conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

•during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the applicable conversion rate on such trading day;

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

•at any time from, and including, February 3, 2025 for 2025 Notes and May 15, 2026 for 2026 Notes, until the close of business on the second scheduled trading day immediately before the maturity date for the 2025 Notes and 2026 Notes.

The Company may not redeem the 2025 Notes and 2026 Notes at its option before maturity. If a “fundamental change” (as defined in the 2025 Indenture and 2026 Indenture) occurs, then, except as described in the 2025 Indenture and 2026 Indenture, noteholders may require the Company to repurchase their 2025 Notes and 2026 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes and 2026 Notes to be repurchased, plus accrued and unpaid interest, if any.

As of March 31, 2024, none of the conditions permitting holders to convert their 2025 Notes and 2026 Notes had been satisfied and no shares of the Company’s common stock had been issued in connection with any conversions of the 2025 Notes and 2026 Notes during the three months ended March 31, 2024. Based on the closing price of the Company's common stock of $56.29 per share on March 31, 2024, the conversion value of the 2026 Notes was less than the principal amount of the 2026 Notes outstanding on a per note basis, and the conversion value of the 2025 Notes was greater than the principal amount of the 2025 Notes outstanding on a per note basis.

The 2025 Notes and 2026 Notes consisted of the following (in millions):

	March 31, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.6)		(0.2)
Net carrying amount	$	374.4	$	23.1

	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three months ended March 31, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	0.6		0.6
Total interest expense recognized	$	0.7	$	0.7

2025 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	—		—
Total interest expense recognized	$	0.1	$	0.1

Convertible Notes Hedges

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company entered into privately negotiated convertible note hedge transactions (the “2026 Notes Hedges” and the “2025 Notes Hedges”), and together, the “Notes Hedges”) with certain of the initial purchasers or their respective affiliates and/or other financial institutions (the “Option Counterparties”). As of March 31, 2024, the 2026 Notes Hedges provide the Company with the option to acquire, on a net settlement basis, approximately 2.0 million shares of common stock at a strike price of $191.94, which is equal to the number of shares of common stock that notionally underlie the 2026 Notes and correspond to the conversion price of the 2026 Notes. As of March 31, 2024, the 2025 Notes Hedges provided the Company with the option to acquire, on a net settlement basis, approximately 0.5 million shares of common stock at a strike price of $51.67, which is equal to the number of shares of common stock that notionally underlie the 2025 Notes and correspond to the conversion price of the 2025 Notes. If the Company elects cash settlement and exercises the Notes Hedges, the aggregate amount of cash received from the Option Counterparties will cover the aggregate amount of cash that the Company would be required to pay to the holders of the Notes, less the principal amount thereof. The Notes Hedges do not meet the criteria for separate accounting as a derivative as they are indexed to the Company’s stock and are accounted for as freestanding financial instruments.

Convertible Notes Warrants

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company also sold net-share-settled warrants (the “2026 Notes Warrants” and the “2025 Notes Warrants,” respectively, and together, the “Notes Warrants”) in privately negotiated transactions with the Option Counterparties. The strike price of the 2026 Notes Warrants and 2025 Notes Warrants was approximately $295.29 and $81.05 per share, respectively, and is subject to certain adjustments under the terms of their respective Notes Warrants. As a result of the 2026 Notes Warrants and 2025 Notes Warrants and related transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price for any fiscal quarter is over $295.29 for the 2026 Notes Warrants and $81.05 for the 2025 Notes Warrants. The 2026 Notes Warrants and the 2025 Notes Warrants expire over a period of 80 trading days commencing on February 15, 2027 and over a period of 100 trading days commencing on November 1, 2025, respectively, and may be settled in net shares of common stock or net cash at the Company’s election. As of March 31, 2024, 2.0 million warrant shares and 0.5 million warrant shares were outstanding for the 2026 Notes Warrants and 2025 Notes Warrants, respectively.

Derivatives

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company’s derivative financial instruments consist of non-deliverable and deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net loss of $0.2 million during the three months ended March 31, 2024. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net gain of $0.4 million during the three months ended March 31, 2023. Gains and losses on these contracts are recorded in net other expense (income) and net interest expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.

Fair Value Measurement

The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

The carrying value of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments.

All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of March 31, 2024 and December 31, 2023, $54.5 million and $45.3 million, respectively of the Company’s cash, cash equivalents and restricted cash balance related to Level 1 investments.

The Company has a deferred compensation plan, which is funded through Company owned life insurance (“COLI”) policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was $13.9 million and $12.6 million as of March 31, 2024 and December 31, 2023, respectively.

The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of March 31, 2024 and December 31, 2023 were immaterial.

The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 7, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of March 31, 2024 and December 31, 2023.

The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease.

The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of March 31, 2024 and December 31, 2023 was $328.9 million and $316.1 million, respectively. The approximate fair value of the 2025 Notes as of March 31, 2024 and December 31, 2023 was $28.3 million and $32.4 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):

	Three Months Ended March 31,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	154.2	$	—	$	154.2	$	175.5	$	—	$	175.5
Fixed fee percent complete contracts	14.9		—		14.9		14.8		—		14.8
Fixed fee contracts	40.7		—		40.7		36.3		—		36.3
Reimbursable expenses	3.6		—		3.6		2.5		—		2.5
Total professional services fees	213.4		—		213.4		229.1		—		229.1
Other services revenue*	1.2		0.3		1.5		1.4		0.3		1.7
Total services	214.6		0.3		214.9		230.5		0.3		230.8
Software and hardware	—		0.4		0.4		—		0.6		0.6
Total revenues	$	214.6	$	0.7	$	215.3	$	230.5	$	0.9	$	231.4

*Other services revenue primarily consists of hosting fees, maintenance, training, internally developed SaaS revenue and partner referral fees.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):

	Three Months Ended March 31,
	2024		2023
United States	$	205.6	$	223.5
Other countries	9.7		7.9
Total revenues	$	215.3	$	231.4

XML

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Restricted stock activity

Restricted stock activity for the three months ended March 31, 2024 was as follows (shares in thousands):

 

	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.04
Awards vested	(194)	73.93
Awards forfeited	(17)	68.42
Restricted stock awards outstanding at March 31, 2024	698	$	69.50

XML

Net Income per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Basic and diluted net income per share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):

	Three Months Ended
	March 31,
	2024		2023
Net income, basic	$	11,555	$	26,800
Add back interest expense on convertible notes, net of tax	534		560
Net income, diluted	$	12,089	$	27,360
Basic:
Weighted-average shares of common stock outstanding	34,149		33,914
Shares used in computing basic net income per share	34,149		33,914
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	177		154
Shares issuable for acquisition consideration (1)	149		199
Shares issuable for conversion of convertible senior notes	2,430		2,430
Shares used in computing diluted net income per share	36,905		36,697
Basic net income per share	$	0.34	$	0.79
Diluted net income per share	$	0.33	$	0.75

(1)For the three months ended March 31, 2024, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Purchase Agreement with Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (collectively, “Talos”); (iii) the Stock Purchase Agreement with the shareholders of Izmul S.A. (“Overactive”); (iv) the Purchase Agreement with the shareholders of Ameex Technologies Corporation (“Ameex”); and (v) the Purchase Agreement with the shareholders of SMEDIX, Inc. (“SMEDIX”), as part of the consideration. For the three months ended March 31, 2023, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon; (ii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); (iii) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”); (iv) the Purchase Agreement with Talos; (v) the Stock Purchase Agreement with the shareholders of Overactive; (vi) the Stock Purchase Agreement with the shareholders of Inflection Point Systems, Inc.; and (vii) the Purchase Agreement with the shareholders of Ameex, as part of the consideration.

Antidilutive securities excluded from computation of earnings per share

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):

	Three Months Ended
	March 31,
	2024	2023
Restricted stock and performance stock awards subject to vesting	109	276
Warrants related to the issuance of convertible senior notes	2,431	2,431
Total anti-dilutive securities	2,540	2,707

XML

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2024

Balance Sheet Related Disclosures [Abstract]

Accounts receivable

	March 31, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	97.6	$	119.9
Unbilled revenues, net	74.2		59.1
Total	$	171.8	$	179.0

Other current assets

Other non-current assets:
Non-current unbilled revenue	$	1.3	$	2.2
Company owned life insurance asset	13.9		12.6
Long term deposits	1.9		1.8
Credit facility deferred finance fees, net	1.0		1.0
Other non-current assets	13.6		13.2
Deferred income taxes	22.2		21.6
Total	$	53.9	$	52.4

Property and equipment

Property and equipment:
Computer hardware (useful life of 3 years)	$	25.5	$	26.7
Software (useful life of 1 to 7 years)	9.1		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.8		7.8
Less: Accumulated depreciation	(36.3)		(36.2)
Total	$	10.4	$	12.0

Other non-current assets

Other current assets:
Miscellaneous receivables	$	3.5	$	3.1
Contractual commitment asset	3.4		3.0
Income tax receivable	3.2		2.7
Other current assets	3.4		3.6
Total	$	13.5	$	12.4

Other current liabilities

Other current liabilities:
Estimated fair value of contingent consideration liability (Note 9)	$	6.4	$	4.5
Accrued variable compensation	13.1		15.9
Current operating lease liabilities	6.4		7.0
Payroll related costs	11.2		11.1
Deferred revenues	3.3		5.5
Income tax payable	4.7		1.5
Other current liabilities	5.8		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	1.8		1.3
Accrued IT expenses	5.1		5.0
Total	$	60.1	$	59.8

Other non-current liabilities

	March 31, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	5.4	$	5.9
Reserve for uncertain tax positions	18.4		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	4.6		5.0
Non-current software accrual	1.7		2.6
Total	$	42.6	$	42.2

XML

Allowance for Credit Losses (Tables)

3 Months Ended

Mar. 31, 2024

Credit Loss [Abstract]

Allowance for credit losses

Activity in the allowance for credit losses is summarized as follows (in millions):

	Three Months Ended March 31,
	2024		2023
Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	(0.1)		—
Other (1)	(0.5)		(1.2)
Balance at March 31	$	1.9	$	4.6

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

XML

Business Combinations (Tables)

3 Months Ended

Mar. 31, 2024

Business Combinations [Abstract]

Allocation of total purchase price consideration

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):

	SMEDIX
Cash, net of cash acquired	$	33.2
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.6

(1)Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the closing date of the acquisition.

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of March 31, 2024, the fair value of the contingent consideration was $6.4 million.

The Company has estimated the preliminary allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):

	SMEDIX
Acquired tangible assets	$	4.9
Identified intangible assets	8.9
Liabilities assumed	(3.1)
Goodwill	32.9
Total allocable purchase price consideration	$	43.6

Schedule of finite-lived intangible assets acquired

The following table presents details of the intangible assets acquired during the three months ended March 31, 2024.

	Weighted Average Useful Life	Estimated Useful Life	SMEDIX
Customer relationships	6 years	6 years	$	7.0
Customer backlog	1 year	1 year	1.7
Non-compete agreements	5 years	5 years	0.1
Trade name	1 year	1 year	0.1
Total acquired intangible assets			$	8.9

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2024 are as follows (in millions):

 

Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.9
Effect of foreign currency translation adjustments	(0.5)
Balance at March 31, 2024	$	613.8

Intangible assets

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):

	March 31, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	122.9	$	(51.1)	$	71.8	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.6)		0.6		1.1		(0.6)		0.5
Customer backlog	1.7		(0.4)		1.3		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	8.8		(7.2)		1.6		8.5		(6.7)		1.8
Total	$	135.5	$	(60.1)	$	75.4	$	126.5	$	(55.4)	$	71.1

Estimated useful lives of intangible assets

The estimated useful lives of identifiable intangible assets are as follows:

 

Customer relationships	5 - 10 years
Non-compete agreements	4 - 5 years
Customer backlog	1 year
Trade name	1 year
Developed software	1 - 7 years

Estimated annual amortization expense

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):

2024 remaining	$	13.9
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

XML

Long-term Debt (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of long-term debt instruments

The 2025 Notes and 2026 Notes consisted of the following (in millions):

	March 31, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.6)		(0.2)
Net carrying amount	$	374.4	$	23.1

	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three months ended March 31, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	0.6		0.6
Total interest expense recognized	$	0.7	$	0.7

2025 Notes

	Three Months Ended
	March 31,
	2024		2023
Coupon interest	$	0.1	$	0.1
Amortization of debt issuance costs	—		—
Total interest expense recognized	$	0.1	$	0.1

XML

Derivatives (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of notional amounts of outstanding derivative positions

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	28.2	$	26.2
Total derivatives not designated as hedges	$	28.2	$	26.2

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Summary of lease liabilities

Supplemental balance sheet information related to leases was as follows (in millions):

	March 31, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.4	$	7.0
Operating lease liabilities	17.9		16.4
Total	$	24.3	$	23.4

Future minimum leases payments under ASC topic 842

Future minimum lease payments as of March 31, 2024 were as follows (in millions):

	March 31, 2024 (unaudited)
2024 remaining	$	5.4
2025	6.9
2026	4.8
2027	4.5
2028	3.4
Thereafter	2.0
Total future lease payments	27.0
Less implied interest	(2.7)
Total	$	24.3

XML

Revenue - Services Revenue (Details) - Technology Service	3 Months Ended
	Mar. 31, 2024
Minimum
Disaggregation of Revenue [Line Items]
Notice period to cancel or terminate contract	10 days
Maximum
Disaggregation of Revenue [Line Items]
Notice period to cancel or terminate contract	30 days

XML

Revenue - Deferred Revenue (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue balance	$ 3.3	$ 5.5

XML

Revenue - Disaggregation of Revenue by Revenue Source and Pattern of Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 215,304	$ 231,408
Over Time
Disaggregation of Revenue [Line Items]
Revenues	214,600	230,500
Point In Time
Disaggregation of Revenue [Line Items]
Revenues	700	900
Services
Disaggregation of Revenue [Line Items]
Revenues	214,900	230,800
Services | Over Time
Disaggregation of Revenue [Line Items]
Revenues	214,600	230,500
Services | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	300	300
Professional services
Disaggregation of Revenue [Line Items]
Revenues	213,400	229,100
Professional services | Over Time
Disaggregation of Revenue [Line Items]
Revenues	213,400	229,100
Professional services | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Professional services | Time and materials contracts
Disaggregation of Revenue [Line Items]
Revenues	154,200	175,500
Professional services | Time and materials contracts | Over Time
Disaggregation of Revenue [Line Items]
Revenues	154,200	175,500
Professional services | Time and materials contracts | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Professional services | Fixed fee percent complete contracts
Disaggregation of Revenue [Line Items]
Revenues	14,900	14,800
Professional services | Fixed fee percent complete contracts | Over Time
Disaggregation of Revenue [Line Items]
Revenues	14,900	14,800
Professional services | Fixed fee percent complete contracts | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Professional services | Fixed fee contracts
Disaggregation of Revenue [Line Items]
Revenues	40,700	36,300
Professional services | Fixed fee contracts | Over Time
Disaggregation of Revenue [Line Items]
Revenues	40,700	36,300
Professional services | Fixed fee contracts | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Professional services | Reimbursable expenses
Disaggregation of Revenue [Line Items]
Revenues	3,600	2,500
Professional services | Reimbursable expenses | Over Time
Disaggregation of Revenue [Line Items]
Revenues	3,600	2,500
Professional services | Reimbursable expenses | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Other services
Disaggregation of Revenue [Line Items]
Revenues	1,500	1,700
Other services | Over Time
Disaggregation of Revenue [Line Items]
Revenues	1,200	1,400
Other services | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	300	300
Software and hardware
Disaggregation of Revenue [Line Items]
Revenues	400	600
Software and hardware | Over Time
Disaggregation of Revenue [Line Items]
Revenues	0	0
Software and hardware | Point In Time
Disaggregation of Revenue [Line Items]
Revenues	$ 400	$ 600

XML

Revenue - Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 215,304	$ 231,408
United States
Disaggregation of Revenue [Line Items]
Revenues	205,600	223,500
Other countries
Disaggregation of Revenue [Line Items]
Revenues	$ 9,700	$ 7,900

XML

Stock-Based Compensation - Stock Award Plans (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock-Based Compensation [Abstract]
Requisite service period (in years)	3 years
Stock compensation	$ 12.4	$ 6.8
Stock-based compensation expense for retirement savings plan contributions	1.0	1.1
Associated current and future income tax benefits recognized	3.7	$ 1.8
Incremental share based compensation expense	5.6
Performance Stock Awards
Stock-Based Compensation [Abstract]
Stock compensation	0.1
Total unrecognized compensation cost related to non-vested share-based awards	$ 0.7
Unrecognized compensation cost, weighted-average period for recognition (in years)	3 years
Restricted stock and performance stock awards subject to vesting
Stock-Based Compensation [Abstract]
Total unrecognized compensation cost related to non-vested share-based awards	$ 37.0
Unrecognized compensation cost, weighted-average period for recognition (in years)	2 years
2012 Long term incentive plan
Stock-Based Compensation [Abstract]
Maximum number of shares authorized under plan (in shares)	8.5
Number of shares available for issuance under the incentive plan (in shares)	1.8

XML

Stock-Based Compensation - Restricted Stock Activity (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Performance Stock Awards
RSAs (Shares)
Awards granted (in shares) | shares	10,842
Weighted-Average Grant Date Fair Value
Awards granted (in dollars per share) | $ / shares	$ 80.90
2012 Long term incentive plan | Restricted stock and performance stock awards subject to vesting
RSAs (Shares)
Restricted stock awards outstanding at beginning of period (in shares) | shares	714,000
Awards granted (in shares) | shares	195,000
Awards vested (in shares) | shares	(194,000)
Awards forfeited (in shares) | shares	(17,000)
Restricted stock awards outstanding at end of period (in shares) | shares	698,000
Weighted-Average Grant Date Fair Value
Awards outstanding at beginning of period (in dollars per share) | $ / shares	$ 70.80
Awards granted (in dollars per share) | $ / shares	69.04
Awards vested (in dollars per share) | $ / shares	73.93
Awards forfeited (in dollars per share) | $ / shares	68.42
Awards outstanding at end of period (in dollars per share) | $ / shares	$ 69.50

XML

Net Income per Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Earnings Per Share [Abstract]
Net income	$ 11,555,000	$ 26,800,000
Add back interest expense on convertible notes, net of tax	534,000	560,000
Net income, diluted	$ 12,089,000	$ 27,360,000
Basic:
Weighted-average shares of common stock outstanding	34,149	33,914
Shares used in computing basic net income per share	34,149	33,914
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	177	154
Shares issuable for acquisition consideration (in shares)	149	199
Shares issuable for conversion of convertible senior notes (in shares)	2,430	2,430
Shares used in computing diluted net income per share	36,905	36,697
Basic net income per share (in dollars per share)	$ 0.34	$ 0.79
Diluted net income per share (in dollars per share)	$ 0.33	$ 0.75
Shares authorized to repurchase			$ 375,000,000

XML

Net Income per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	2,540	2,707
Restricted stock and performance stock awards subject to vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	109	276
Warrants related to the issuance of convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	2,431	2,431

XML

Net Income per Share - Additional Information (Details) - USD ($) shares in Millions	Mar. 31, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Shares authorized to repurchase		$ 375,000,000
Cumulative amount repurchased	$ 291,100,000
Cumulative number of shares repurchased (in shares)	16.5

XML

Balance Sheet Components - Accounts Receivable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Billed accounts receivable, net	$ 97,600	$ 119,900
Unbilled revenues, net	74,200	59,100
Total	$ 171,838	$ 178,998

XML

Balance Sheet Components - Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Offsetting [Abstract]
Miscellaneous receivables	$ 3,500	$ 3,100
Contractual commitment asset	3,400	3,000
Income tax receivable	3,200	2,700
Other current assets	3,400	3,600
Other current assets	$ 13,548	$ 12,431

XML

Balance Sheet Components - Property and Equipment) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property and Equipment [Abstract]
Less: Accumulated depreciation	$ (36,300)	$ (36,200)
Property and equipment, net	10,375	11,996
Computer hardware
Property and Equipment [Abstract]
Property and equipment	$ 25,500	26,700
Useful life	3 years
Software
Property and Equipment [Abstract]
Property and equipment	$ 9,100	9,200
Furniture and fixtures
Property and Equipment [Abstract]
Property and equipment	$ 4,300	4,500
Useful life	5 years
Leasehold improvements
Property and Equipment [Abstract]
Property and equipment	$ 7,800	$ 7,800
Useful life	5 years
Minimum | Software
Property and Equipment [Abstract]
Useful life	1 year
Maximum | Software
Property and Equipment [Abstract]
Useful life	7 years

XML

Balance Sheet Components - Other Non-current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Offsetting [Abstract]
Non-current unbilled revenue	$ 1,300	$ 2,200
Company owned life insurance asset	13,900	12,600
Long term deposits	1,900	1,800
Credit facility deferred finance fees, net	1,000	1,000
Other non-current assets	13,600	13,200
Deferred income taxes	22,200	21,600
Other non-current assets	$ 53,936	$ 52,364

XML

Balance Sheet Components - Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Other current liabilities:
Estimated fair value of contingent consideration liability	$ 6,400	$ 4,500
Accrued variable compensation	13,100	15,900
Current operating lease liabilities	6,400	7,000
Payroll related costs	11,200	11,100
Deferred revenues	3,300	5,500
Income tax payable	4,700	1,500
Other current liabilities	5,800	4,800
Accrued medical claims expense	2,300	3,200
Professional fees	1,800	1,300
Accrued IT expenses	5,100	5,000
Total	$ 60,104	$ 59,784

XML

Balance Sheet Components - Other Non-Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Other non-current liabilities:
Deferred income taxes	$ 5,400	$ 5,900
Unrecognized Tax Benefits, Income Tax Penalties Accrued	18,400	17,700
Deferred compensation liability	12,500	11,000
Non-current software accrual	1,700	2,600
Other non-current liabilities	4,600	5,000
Total	$ 42,566	$ 42,189

XML

Allowance for Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 2,500	$ 5,800
Charges to expense, net of recoveries	(100)	0
Other (1)	(500)	(1,200)
Balance at March 31	$ 1,900	$ 4,600

XML

Business Combinations - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 16, 2024	Mar. 31, 2024	Mar. 31, 2023
Business Acquisition [Line Items]
Acquisition costs		$ 1,393	$ 79
SMEDIX
Business Acquisition [Line Items]
Total purchase price	$ 43,600
Acquisition costs	1,700
Tax deductible amount of Goodwill	$ 33,600

XML

Business Combinations - SMEDIX (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Jan. 16, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 613,790		$ 581,387
SMEDIX
Business Acquisition [Line Items]
Cash paid for acquisition		$ 33,200
Company common stock issued at closing		3,800
Initial fair value estimate of additional earnings-based contingent consideration	$ 6,400	6,400
Net working capital settlement		200
Total purchase price		43,600
Contingent consideration, maximum cash payout		14,400
Acquired tangible assets		4,900
Identified intangible assets		8,900
Liabilities assumed		(3,100)
Goodwill		$ 32,900

XML

Business Combinations - Intangible Assets Acquired (Details) - SMEDIX $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Finite-Lived Intangible Assets, Gross [Abstract]
SMEDIX	$ 8.9
Customer relationships
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	6 years
Estimated Useful Life	6 years
SMEDIX	$ 7.0
Customer backlog
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	1 year
Estimated Useful Life	1 year
SMEDIX	$ 1.7
Non-compete agreements
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	5 years
Estimated Useful Life	5 years
SMEDIX	$ 0.1
Trade name
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	1 year
Estimated Useful Life	1 year
SMEDIX	$ 0.1

XML

Goodwill and Intangible Assets - Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Balance at December 31, 2023	$ 581,387
Purchase price allocation for SMEDIX	32,900
Effect of foreign currency translation adjustments	(500)
Balance at March 31, 2024	$ 613,790

XML

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	$ 135,500	$ 126,500
Accumulated Amortization	(60,100)	(55,400)
Net Carrying Amounts	75,430	71,118
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	122,900	116,100
Accumulated Amortization	(51,100)	(47,300)
Net Carrying Amounts	71,800	68,800
Non-compete agreements
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	1,200	1,100
Accumulated Amortization	(600)	(600)
Net Carrying Amounts	600	500
Customer backlog
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	1,700	0
Accumulated Amortization	(400)	0
Net Carrying Amounts	1,300	0
Trade name
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	900	800
Accumulated Amortization	(800)	(800)
Net Carrying Amounts	100	0
Developed software
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	8,800	8,500
Accumulated Amortization	(7,200)	(6,700)
Net Carrying Amounts	$ 1,600	$ 1,800

XML

Goodwill and Intangible Assets - Estimated Useful Lives (Details)	Mar. 31, 2024
Customer relationships | Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	5 years
Customer relationships | Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	10 years
Non-compete agreements | Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	4 years
Non-compete agreements | Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	5 years
Customer backlog
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Trade name
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Developed software | Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Developed software | Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	7 years

XML

Goodwill and Intangible Assets - Estimated Amortization Expense (Details) $ in Millions	Mar. 31, 2024 USD ($)
Estimated Amortization Expense [Abstract]
2024 remaining	$ 13.9
2025	13.4
2026	10.9
2027	8.5
2028	7.4
Thereafter	$ 21.3

XML

Long-term Debt - Revolving Credit Facility (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 29, 2023
Line of Credit [Abstract]
Payment for credit facility financing fees	$ 0	$ 683,000
Convertible debt | Minimum
Line of Credit [Abstract]
Line of Credit Facility, Commitment Fee Percentage	0.15%
Convertible debt | Maximum
Line of Credit [Abstract]
Line of Credit Facility, Commitment Fee Percentage	0.20%
Conversion Circumstance One | Convertible debt
Line of Credit [Abstract]
Conversion rate of the notes on trading day (as percent)	130.00%
Revolving credit facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum
Line of Credit [Abstract]
Margin interest rate percentage	1.00%
Revolving credit facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum
Line of Credit [Abstract]
Margin interest rate percentage	2.00%
Revolving credit facility | Credit agreement
Line of Credit [Abstract]
Allowable amount of letters of credit for issuance	$ 10,000,000
Additional commitment increase	75,000,000
Maximum borrowing capacity			$ 300,000,000
Payment for credit facility financing fees		$ 800,000
Available borrowing capacity	$ 300,000,000
Revolving credit facility | Credit agreement | Prime rate
Line of Credit [Abstract]
Interest rate at end of period	8.50%
Revolving credit facility | Credit agreement | Prime rate | Minimum
Line of Credit [Abstract]
Margin interest rate percentage	0.00%
Revolving credit facility | Credit agreement | Prime rate | Maximum
Line of Credit [Abstract]
Margin interest rate percentage	1.00%
Revolving credit facility | Credit agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit [Abstract]
Interest rate at end of period	5.34%

XML

Long-term Debt - Convertible Senior Notes (Additional Notes) (Details) $ / shares in Units, $ in Thousands			3 Months Ended
	Nov. 09, 2021 USD ($) $ / shares	Aug. 14, 2020 USD ($) $ / shares	Mar. 31, 2024 USD ($) day $ / shares Rate	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Share price at closing (in dollars per share) | $ / shares			$ 56.29
Retained earnings			$ 488,751	$ 477,196
Long-term debt, net			$ 397,446	396,874
2025 Notes | Warrants related to the issuance of convertible senior notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share) | $ / shares			$ 81.05
2026 Notes | Warrants related to the issuance of convertible senior notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share) | $ / shares			$ 295.29
Convertible debt | Conversion Circumstance One
Debt Instrument [Line Items]
Conversion rate of the notes on trading day (as percent)			130.00%
Threshold trading days (whether or not consecutive) | day			20
Consecutive trading day period (in days) | day			30
Convertible debt | Conversion Circumstance Two
Debt Instrument [Line Items]
Conversion rate of the notes on trading day (as percent) | Rate			98.00%
Threshold trading days (whether or not consecutive) | day			5
Consecutive trading day period (in days) | day			10
Convertible debt | 2025 Notes
Debt Instrument [Line Items]
Aggregated principal amount		$ 230,000
Interest rate stated, percentage		1.25%
Shares conversion rate		19.3538
Initial conversion price (in dollars per share) | $ / shares		$ 51.67
Principal			$ 23,300	23,300
Long-term debt, net			$ 23,100	23,000
Convertible debt | 2026 Notes
Debt Instrument [Line Items]
Aggregated principal amount	$ 380,000
Interest rate stated, percentage			0.125%
Shares conversion rate	5.2100
Initial conversion price (in dollars per share) | $ / shares	$ 191.94
Principal			$ 380,000	380,000
Long-term debt, net			$ 374,400	$ 373,900

XML

Long-term Debt - Liability and Equity Component of Note (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Long-term debt:
Net carrying amount	$ 397,446	$ 396,874
Convertible debt | 2025 Notes
Long-term debt:
Principal	23,300	23,300
Less: Unamortized debt issuance costs	(200)	(300)
Net carrying amount	23,100	23,000
Convertible debt | 2026 Notes
Long-term debt:
Principal	380,000	380,000
Less: Unamortized debt issuance costs	(5,600)	(6,100)
Net carrying amount	$ 374,400	$ 373,900

XML

Long-term Debt - Interest Expense on Note (Details) - Senior notes - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
2025 Notes
Debt Instrument [Line Items]
Coupon interest	$ 100	$ 100
Amortization of debt issuance costs	0	0
Total interest expense recognized	100	100
2026 Notes
Debt Instrument [Line Items]
Coupon interest	100	100
Amortization of debt issuance costs	600	600
Total interest expense recognized	$ 700	$ 700

XML

Long-term Debt - Convertible Note Hedges and Warrants (Details) - $ / shares shares in Millions			3 Months Ended
	Nov. 09, 2021	Aug. 14, 2020	Mar. 31, 2024
2025 Notes
Debt Instrument [Line Items]
Expiration period for Notes Warrants in trading days			100 days
2026 Notes
Debt Instrument [Line Items]
Expiration period for Notes Warrants in trading days			80 days
Convertible note hedges | 2025 Notes
Debt Instrument [Line Items]
Conversion option to acquire shares (in shares)			0.5
Strike price (in dollars per share)		$ 51.67
Convertible note hedges | 2026 Notes
Debt Instrument [Line Items]
Conversion option to acquire shares (in shares)			2.0
Strike price (in dollars per share)	$ 191.94
Warrant | 2025 Notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share)			$ 81.05
Warrant | 2026 Notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share)			$ 295.29

XML

Income Taxes (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate	30.00%	26.60%

XML

Derivatives - Notional Amounts (Details) - Total derivatives not designated as hedges - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Notional Disclosures [Abstract]
Derivative notional amounts	$ 28,200		$ 26,200
Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net	(200)	$ 400
Foreign exchange contracts
Notional Disclosures [Abstract]
Derivative notional amounts	$ 28,200		$ 26,200

XML

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
COLI asset	$ 13.9	$ 12.6
Level 2 | 2025 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Note, debt instrument	28.3	32.4
Level 2 | 2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Note, debt instrument	328.9	316.1
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 54.5	$ 45.3

XML

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lessee, Lease, Description [Line Items]
Operating lease expense	$ 3.0	$ 3.3
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	7 years

XML

Leases - Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Other current liabilities	$ 6,400	$ 7,000
Operating lease liabilities	17,915	16,446
Total	$ 24,300	$ 23,400

XML

Leases - Future Minimum Lease Payments under ASC Topic 842 (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
2024 remaining	$ 5.4
2025	6.9
2026	4.8
2027	4.5
2028	3.4
Thereafter	2.0
Total future lease payments	27.0
Less implied interest	(2.7)
Total	$ 24.3	$ 23.4

XML

Subsequent Events (Details) - Subsequent Event $ / shares in Units, $ in Millions	May 05, 2024 USD ($) $ / shares
Subsequent Event [Line Items]
Cash paid per share in business acquisition (in dollars per share) | $ / shares	$ 76.00
Forecast | Plano Holdco, Inc.
Subsequent Event [Line Items]
Termination fee | $	$ 162.6